Benutzer:Rjh/Chemie

Diflorason C₂₆H₃₂F₂O₇ 494.525 g/mol 01-13-8 01-13-8 Anti-Bacterial Agents; ATC:J01DF01 For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.s
Cefmenoxim C₁₆H₁₇N₉O₅S₃ 511.562 g/mol 01-24-1 01-24-1 Antibacterials for Systemic Use; ATC:J01DH03 For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicron, or Bacteroides uniformis, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to Staphylococcus aureus (methicillin susceptible isolates only), Streptococcus agalactiae, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species, Porphyromonas asaccharolytica, or Prevotella bivia, (3) community acquired pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only) including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates only), or Moraxella catarrhalis, (4) complicated urinary tract infections including pyelonephritis due to Escherichia coli, including cases with concurrent bacteremia, or Klebsiella pneumoniae, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to Streptococcus agalactiae, Escherichia coli, Bacteroides fragilis, Porphyromonas asaccharolytica, Peptostreptococcus species, or Prevotella bivia.s
Diphenidol C₂₁H₂₇NO 309.445 g/mol 19-11-4 19-11-4 Trypanocidal Agents; Antiprotozoal Agents; Antifungal Agents; ATC:P01CX01 For the treatment of pneumonia due to Pneumocystis carinii.s
Oxyphenonium, en, C₂₁H₃₄NO₃ 348.5 g/mol 50-10-2 50-10-2 Antihistamines; ATC:R06AX27 For the relief of symptoms of seasonal allergic rhinitis, pruritus, reduction in the number of hives in patients with chronic idiopathic urticaria.s
Metharbital, en, C₉H₁₄N₂O₃ 198.219 g/mol 50-11-3 50-11-3 Anti-bacterial Agents; Anti-Infectives; Quinolones; ATC:J01MA12; ATC:S01AX19 For the treatment of Bacterial infection of; Respiratory tract, Urinary tract, GI, CNS and Immuno compromised patients caused by: S.pneumoniae, H.influenzae, M.catarrhalis, S.aureus, H.parainfluenzae, P.aeruginosa, S.marcescens, E.coli, K.pneumoniae, C.pns
Mephenytoin, en, C₁₂H₁₄N₂O₂ 218.252 g/mol 50-12-4 50-12-4 Mydriatics; Bronchodilator Agents; Antiarrhythmic Agents; Adjuvants; Antimuscarinics; Antispasmodics; ATC:A03BA03 For treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Also used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis.s
Floxuridin, en, C₉H₁₁FN₂O₅ 246.193 g/mol 50-91-9 50-91-9 Free Radical Scavengers; Antiparkinson Agents; Antidyskinetics; Antioxidants; ATC:N04BC05 For the treatment of signs and symptoms of idiopathic Parkinson's diseases
beta-d-Glucose C₆H₁₂O₆ 180.157 g/mol 50-99-7 50-99-7 Gastrointestinal Agents; Histamine Agonists; ATC:V04CG02 For use clinically to test gastric secretory function.s
alpha-d-Glucose C₆H₁₂O₆ 180.157 g/mol 50-99-7 50-99-7 Anti-allergic Agents; Anti-inflammatory Agents; ATC:D07AC13; ATC:D07XC03; ATC:R01AD09; ATC:R03BA07 The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.s
Dextrothyroxin C₁₅H₁₁I₄NO₄ 776.87 g/mol 51-49-0 51-49-0 Antineoplastic Agents; ATC:G04CA02 Used in the treatment of signs and symptoms of benign prostatic hyperplasia.s
Histaminephosphat C₅H₁₅N₃O₈P₂ 307.14 g/mol 51-74-1 51-74-1 Neuromuscular Nondepolarizing Agents; ATC:M03AC07 Used to provide skeletal muscle relaxation as an adjunct to general anesthesia, for endotracheal intubation or to facilitate mechanical ventilation.s
Pentolinium C₁₅H₃₂N₂ 240.428 g/mol 52-62-0 52-62-0 L-2-Halosäure Dehalogenase inhibitor Not Availables
nicotinamide-adenine-dinucleotide C₂₁H₂₇N₇O₁₄P₂ 663.430 g/mol 53-84-9 53-84-9 Antineoplastic Agents; ATC:L02BG06 For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.s
(s)-(-)-Nicotin]], [[3-((2s)-1-methyl-2-pyrrolidinyl)pyridine C₁₀H₁₄N₂ 162.234 g/mol 54-11-5 54-11-5 Pentaerythritol Tetranitrate Reductase inhibitor Not Availables
Metyrapon C₁₄H₁₄N₂O₁ 226.277 g/mol 54-36-4 54-36-4 Biliverdin Ix Beta Reductase inhibitor Not Availables
Pipobroman C₁₀H₁₆Br₂N₂O₂ 356.054 g/mol 54-91-1 54-91-1 Malate Dehydrogenase inhibitor Not Availables
Betanidin C₁₀H₁₅N₃ 177.25 g/mol 55-73-2 55-73-2 S-Adenosylmethionine Decarboxylase Proenzyme inhibitor Not Availables
Isoflurophat C₆H₁₄FO₃P 184.146 g/mol 55-91-4 55-91-4 Beta-Trypsin inhibitor Not Availables
Felypressin C₄₆H₆₅N₁₃O₁₁S₂ 1040.22 g/mol 56-59-7 56-59-7 Antianemic Agents; ATC:B03XA02 For the treatment of anemia (from renal transplants or certain HIV treatment)s
Demecariumbromid C₃₂H₅₂Br₂N₄O₄ 716.588 g/mol 56-94-0 56-94-0 Bacteriorhodopsin inhibitor Not Availables
000005-formyl-5,6,7,8-tetrahydrofolat C₂₀H₂₃N₇O₇ 473.444 g/mol 58-05-9 58-05-9 Anti-HIV Agents; Radiation-Sensitizing Agents; Antivirals; Antineoplastic Agents; ATC:J05AB12 For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)s
Caffein C₈H₁₀N₄O₂ 194.191 g/mol 58-08-2 58-08-2 Anti-bacterial Agents; ATC:D10AF02; ATC:J01FA01; ATC:S01AA17
Ethacryninsäure C₁₃H₁₂Cl₂O₄ 303.137 g/mol 58-54-8 58-54-8 Antiarrhythmic Agents; Potassium Channel Blockers; ATC:C01BD04 For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythms
Uridin-5-monophosphat C₉H₁₃N₂O₉P₁ 324.183 g/mol 58-97-9 58-97-9 Anti-bacterial Agents; ATC:J01AA11 For the treatment and management of Brucellosis, mycoplasma infection, acne vulgaris, chlamydial infection;Chronic bronchitiss
Uridin-5-diphosphat C₉H₁₄N₂O₁₂P₂ 404.163 g/mol 58-98-0 58-98-0 Dermatologic Agents; Keratolytic Agents; Prodrugs; Teratogens; ATC:D05AX05 Used to treat psoriasis, acne and sun damaged skin (photodamage).s
000002-Sulfhydrylethanol C₂H₆O₁S₁ 78.129 g/mol 60-24-2 60-24-2 Antihypertensive Agents; Carbonic Anhydrase Inhibitors; ATC:S01EC03 For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucomas
Mecamylamin C₁₁H₂₁N 167.291 g/mol 60-40-2 60-40-2 Anticoagulants; Antithrombotic Agents; ATC:B01AE02 For the treatment of heparin-induced thrombocytopenias
Tridihexethyl C₂₁H₃₆NO+ 318.517 g/mol 60-49-1 60-49-1 Chorismate--Pyruvate Lyase inhibitor Not Availables
(3-(o-chlorphenyl)-5-methyl-4-isoxazolyl)penicillin C₁₉H₁₈N₃O₅Cl₁S₁ 435.881 g/mol 61-72-3 61-72-3 Old Yellow Enzyme inhibitor Not Availables
Chlormerodrin C₅H₁₁ClHgN₂O₂ 367.196 g/mol 62-37-3 62-37-3 Diaminopimelate Decarboxylase inhibitor Not Availables
Lipoinsäure C₈H₁₄O₂S₂ 206.317 g/mol 62-46-4 62-46-4 Antineoplastic agents; Antimetabolites; Purine analogues; ATC:L01BB06 For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.s
Nalorphin C₁₉H₂₁NO₃ 311.375 g/mol 62-67-9 62-67-9 Anti-barbituates; Stimulants; GABA receptor antagonists Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates.s
Nandrolonephenpropionat C₂₇H₃₄O₃ 406.557 g/mol 62-90-8 62-90-8 Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A01AC01; ATC:D07AB09; ATC:D07XB02; ATC:H02AB08; ATC:R01AD11; ATC:R03BA06; ATC:S01BA05 For the treatment of perennial and seasonal allergic rhinitis.s
Diphemanilmethylsulfat C₂₁H₂₇NO₄S 389.509 g/mol 62-97-5 62-97-5 Prodrugs; Antivirals; ATC:J05AB For the treatment or suppression of cold sores (herpes labialis), herpes zoster (shingles), genital herpes in immunocompetent individuals, and recurrent genital herpes in HIV-infected individuals.s
000004-androsten-3-17-dion C₁₉H₂₆O₂ 286.413 g/mol 63-05-8 63-05-8 Antispasmodics; Anti-Incontinence Agents; Genitourinary Smooth Muscle Relaxants; ATC:G04BD07 For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).s
Benzquinamid C₂₂H₃₂N₂O₅ 404.5 g/mol 63-12-7 63-12-7 Analgesics; Antitussives; Narcotics; ATC:R05DA03 For relief of moderate to moderately severe pain.s
Cytidin-5-diphosphat C₉H₁₅N₃O₁₁P₂ 403.179 g/mol 63-38-7 63-38-7 Anticonvulsants; Barbiturates; ATC:N03AA03 For the treatment of epilepsys
Uridin-5-triphosphat C₉H₁₁N₂O₁₅P₃ 480.112 g/mol 63-39-8 63-39-8 Anti-anxiety Agents; Hypnotics and Sedatives; Barbiturates; ATC:N05CA For short-term treatment of insomnia and anxiety disorderss
Phenacemid C₉H₁₀N₂O₂ 178.188 g/mol 63-98-9 63-98-9 Hypnotics and Sedatives Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.s
Gallamintriethiodid C₂₄H₄₅N₃O₃ 423.633 g/mol 65-29-2 65-29-2 Anti-inflammatory Agents; Adrenergic Agents; ATC:H02AA02 For partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.s
Cytidin-5-triphosphat C₉H₁₆N₃O₁₄P₃ 483.158 g/mol 65-47-4 65-47-4 Anti-bacterial Agents; Tetracyclines; ATC:D06AA01; ATC:J01AA01 Used primarily to treat Lyme disease, acne, and bronchitis. Also indicated (but rarely used) to treat urinary tract infections, gum disease, malaria, and other bacterial infections such as gonorrhea and chlamydia. One of its other registered uses is the treatment of hyponatremia (low blood sodium concentration) due to the syndrome of inappropriate antidiuretic hormone (SIADH) where fluid restriction alone has been ineffective.s
n-Acetylmethionin C₇H₁₃N₁O₃S₁ 191.245 g/mol 65-82-7 65-82-7 Anti-Infectives; Sulfonamides Treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.s
Orotinsäure C₅H₄N₂O₄ 156.098 g/mol 65-86-1 65-86-1 Anti-HIV Agents; ATC:J05AE01 For the treatment of HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues.s
Uracil mustard C₈H₁₁Cl₂N₃O₂ 252.097 g/mol 66-75-1 66-75-1 Anticoagulants; Antithrombotic Agents; ATC:B01AE06 For treatment of heparin-induced thrombocytopenias
Fluocinolonacetonid C₂₄H₃₀F₂O₆ 452.488 g/mol 67-73-2 67-73-2 Antineoplastic Agents; Photosensitizing Agents; ATC:L01XD02 For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.s
7,9-Dihydro-1h-purine-2,6,8(3h)-trione C₅H₄N₄O₃ 168.112 g/mol 69-93-2 69-93-2 Anesthetics; Local Anesthetics; ATC:N01BA04 For the production of local anesthesia by infiltration and peripheral nerve block. They are not to be used for lumbar or caudal epidural anesthesia.s
000001-proponol C₃H₈O₁ 60.096 g/mol 71-23-8 71-23-8 Antiviral Agents; Nucleic säure Synthesis Inhibitors; ATC:J05AC02 For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults.s
000004-amino-5-hydroxymethyl-2-methylpyrimidine C₆H₉N₃O₁ 139.157 g/mol 73-67-6 73-67-6 Tropinone Reductase-II inhibitor Not Availables
Acetoncyanohydrin C₄H₇N₁O₁ 85.105 g/mol 75-86-5 75-86-5 Antiadrenal; Anticorticosteroids; ATC:H02CA01 Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.s
Perflutren C₃F₈ 188.019 g/mol 76-19-7 76-19-7 Anti-HIV Agents; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; ATC:J05AF06 For the treatment of HIV-1 infection, in combination with other antiretroviral agents.s
Hydrocortamat C₂₇H₄₁NO₆ 475.618 g/mol 76-47-1 76-47-1 Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Enzyme Inhibitors; Immunosuppressive Agents; ATC:D11AX15 For treatment of mild to moderate atopic dermatitis.s
Dicyclomin C₁₉H₃₅NO₂ 309.487 g/mol 77-19-0 77-19-0 Antiglaucomic Agents; Ophthalmics; Carbonic Anhydrase Inhibitors; ATC:S01EC04 For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.s
Procyclidin C₁₉H₂₉NO 287.44 g/mol 77-37-2 77-37-2 Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA06 For the treatment of hypertension.s
Cycrimin C₁₉H₂₉NO 287.44 g/mol 77-39-4 77-39-4 Amebicides; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; ATC:A01AB04; ATC:A07AA07; ATC:G01AA03; ATC:J02AA01 Used to treat potentially life threatening fungal infections.s
Propanolsäure C₃H₆O₂ 74.079 g/mol 79-09-4 79-09-4 Anti-Bacterial Agents; Antifungal Agents; ATC:G01AA04 Used in the topical treatment of vulvovaginal candidiasis.s
Hydroxyacetylsäure; hydroxyethanolsäure C₂H₄O₃ 76.052 g/mol 79-14-1 79-14-1 Anti-Bacterial Agents; Glycopeptide antibacterials; ATC:A07AA09; ATC:J01XA01 For the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci.s
Homatropinmethylbromid C₁₇H₂₄BrNO₃ 370.28 g/mol 80-49-9 80-49-9 Anti-Infectives; Antibiotic Agents; Ophthalmic Antibiotic; Topical Antibiotic For treatment of skin lesions, surface wounds and eye infectionss
Anisotropinmethylbromid C₁₇H₃₂BrNO₂ 362.346 g/mol 80-50-2 80-50-2 Non-Specific Lipid Transfer Protein inhibitor Not *Chlormezanon C₁₁H₁₂ClNO₃S 273.737 g/mol 80-77-3 80-77-3 Synthetic Designed Peptide "Alpha-1" inhibitor Not Availables
Taurocholinsäure C₂₆H₄₅N₁O₇S₁ 515.704 g/mol 81-24-3 81-24-3 Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
Cholinsäure C₂₄H₄₀O₅ 408.577 g/mol 81-25-4 81-25-4 Anti-Arrhythmia Agents; Cardiotonic Agents; Phosphodiesterase Inhibitors; Vasodilator Agents; ATC:C01CX08 For short term treatment of acutely decompensated severe chronic heart failure (CHF).s
Buclizin C₂₈H₃₃ClN₂ 433.028 g/mol 82-95-1 82-95-1 Anti-emetics; ATC:R06AD03 For the treatment or relief of nausea and vomiting.s
Phenindion C₁₅H₁₀O₂ 222.239 g/mol 83-12-5 83-12-5 Antiviral Agents; Reverse Transcriptase Inhibitors; ATC:J05AF08 For the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.s
Deoxycholinsäure C₂₄H₄₀O₄ 392.578 g/mol 83-44-3 83-44-3 Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
Cytidin-5-monophosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol 84-52-6 84-52-6 Antiparkinson Agents; Antidyskinetics; ATC:N04AA01 Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.s
Phytonadion C₃₁H₄₆O₂ 450.696 g/mol 84-80-0 84-80-0 Analgesics; Narcotics; Opiate Agonists; ATC:N01AH05 For treatment and management of pain (systemic) and for use as an anesthesia adjunct.s
Trimeprazin C₁₈H₂₂N₂S 298.447 g/mol 84-96-8 84-96-8 Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
Guanosin-5-monophosphat C₁₀H₁₄N₅O₈P₁ 363.223 g/mol 85-32-5 85-32-5 Anti-Infectives; Anti-bacterial Agents For the treatment of leprosy and dermatitis herpetiformiss
Cytidin-2-monophosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol 85-94-9 85-94-9 Dermatitis herpetiformis suppressant; Dermatologic Agents; Anti-Infectives; Sulfonamides; ATC:J01EB04 For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosums
Guanosin-5-triphosphat C₁₀H₁₆N₅O₁₄P₃ 523.183 g/mol 86-01-1 86-01-1 Antiviral Agents; Oligonucleotides, Antisense; ATC:S01AD08 Vitravene is indicated for the local treatment of CMV retinitis. It is recommended for use by patients with acquired immune deficiency syndrome who are intolerant or have contraindications to other treatments.s
Benztropin C₂₁H₂₅NO 307.429 g/mol 86-13-5 86-13-5 Anti-Infective Agents, Local For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive).s
Brompheniramin C₁₆H₁₉BrN₂ 319.24 g/mol 86-22-6 86-22-6 Fibrinolytic Agents; Platelet Aggregation Inhibitors; ATC:B01AC17 For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.s
Phensuximid C₁₁H₁₁NO₂ 189.211 g/mol 86-34-0 86-34-0 Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; ATC:C09CA08 For the treatment of hypertensions
Ethotoin C₁₁H₁₂N₂O₂ 204.225 g/mol 86-35-1 86-35-1 Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; ATC:C09CA07 For the treatment of hypertension.s
Glucarat C₆H₈O₈₂- 1392.080 g/mol 87-73-0 87-73-0 Anticholesteremic Agents; Antilipemic Agents; ATC:C10AA06 Used as an adjunct to diet for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate.s
Mesalamin C₇H₇NO₃ 153.135 g/mol 89-57-6 89-57-6 Nitroreductase Family Protein inhibitor Not Availables
Salicylhydroxaminsäure C₇H₇N₁O₃ 153.137 g/mol 89-73-6 89-73-6 Antipsychotics; Antiemetics; ATC:N05AA05 Used mainly in the management of psychoses. Also used to control nausea and vomiting.s
(s)-mandelsäure C₈H₈O₃ 152.149 g/mol 90-64-2 90-64-2 Dopaminergics; Neuroprotective Agents; Antiparkinson Agents; Antidyskinetics; Central Nervous System Agents; ATC:N04BD01 For the adjunct treatment for Parkinson's disease.s
Chinaldinsäure C₁₀H₇N₁O₂ 173.171 g/mol 93-10-7 93-10-7 Immunosuppressive Agents; Antivirals; Antimetabolites; Antineoplastic Agents; ATC:L01BC01 For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.s
Aminohippurat C₉H₁₀N₂O₃ 194.187 g/mol 94-16-6 94-16-6 ATC:L03AX13 For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.s
Chlorzoxazon C₇H₄ClNO₂ 169.565 g/mol 95-25-0 95-25-0 Adjuvants, Immunologic; Antinematodal Agents; Antirheumatic Agents; ATC:P02CE01 For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.s

100 .. 1000

Chlorphenesin C₉H₁₁ClO₃ 202.635 g/mol 104-29-0 104-29-0 Analgesic Antagonists; Morphine Antidotes; Antinarcotic Agents; Narcotic Antagonists For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.s
Benzonatat C₃₀H₅₃NO₁₁ 603.742 g/mol 104-31-4 104-31-4 Antimalarials; Anti-Infectives; Anti-Infective Agents, Urinary For the treatment of urinary tract infection and chronic bronchitis.s
Betazol C₅H₉N₃ 111.145 g/mol 105-20-4 105-20-4 Pregnadien derivatives; Progesterones; ATC:G03DB01 Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.s
Aminolevulininsäure C₅H₉NO₃ 131.13 g/mol 106-60-5 106-60-5 Antineoplastic Agents; Protein Kinase Inhibitors; ATC:L01XX28 For the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia (CML). Also indicated for the treatment of pediatric patients with Ph+ chronic phase CML whose disease has recurred after stem cell transplant or who are resistant to interferon-alpha therapy. Also indicated with unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST).s
000002-Aminoethansulfonsäure C₂H₇N₁O₃S₁ 125.142 g/mol 107-35-7 107-35-7 Fertility Agents For treatment of female infertilitys
Butanonsäure C₄H₈O₂ 88.106 g/mol 107-92-6 107-92-6 Beta-Lactamase inhibitor Not Availables
n-Valerinsäure C₅H₁₀O₂ 102.133 g/mol 109-52-4 109-52-4 Antimetabolites; Antineoplastic Agents; ATC:L01BB03 For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.s
Succininsäure C₄H₆O₄ 118.089 g/mol 110-15-6 110-15-6 Benzoylformate Decarboxylase inhibitor Not Availables
Ethchlorvynol C₇H₉ClO 144.598 g/mol 113-18-8 113-18-8 Antidepressants; Antipsychotics; ATC:N05AL01; ATC:N05AL07 Sulpiride is indicated for the treatment of schizophrenia.s
Phenformin C₁₀H₁₅N₅ 205.26 g/mol 114-86-3 114-86-3 Hyaluronate Lyase inhibitor Not Availables
r-Mephobarbital C₁₃H₁₄N₂O₃ 246.262 g/mol 115-38-8 115-38-8 Anti-migraine Agents; Vasoconstrictor Agents; Anti-inflammatory Agents; ATC:N02CC07 For the acute treatment of migraine attacks with or without aura in adults.s
Paramethadion C₇H₁₁NO₃ 157.167 g/mol 115-67-3 115-67-3 Antiarrhythmic Agents; ATC:R03DC03 For the treatment of asthmas
Edrophonium C₁₀H₁₆NO+ 166.24 g/mol 116-38-1 116-38-1 Anti-HIV Agents For treatment of HIV AIDSs
3,5,7,3',4'-Pentahydroxyflavon C₁₅H₁₀O₇ 302.240 g/mol 117-39-5 117-39-5 Hypoglycemic Agents For treatment of diabetes (type I and II)s
Diatrizoat C₁₁H₉I₃N₂O₄ 613.914 g/mol 117-96-4 117-96-4 Anti-Asthmatic Agents For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.s
1,2-Dihydroxybenzen C₆H₆O₂ 110.112 g/mol 120-80-9 120-80-9 Anti-baldness Agents; Antihyperplasia Agents; ATC:G04CB02 For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland.s
4-Hydroxy-3-methoxybenzoat C₈H₇O₄ 167.141 g/mol 121-34-6 121-34-6 Anti-Infective Agents; Antibacterial Agents; Protein Synthesis Inhibitors; ATC:J01XX08 For the treatment of bacterial infections caused by susceptible strains of vancomycin resistant Enterococcus faecium, Staphylococcal aureus (methicillin resistant and susceptible strains), Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae.s
n-(2-Amino-propyl)-1,4-diaminobutane C₇H₁₉N₃ 145.247 g/mol 124-20-9 124-20-9 Cyclooxygenase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; ATC:L01XX33; ATC:M01AH01 For relief and management of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, acute pain, primary dysmenorrhea and oral adjunct to usual care for patients with familial adenomatous polyposiss
Butabarbital C₁₀H₁₆N₂O₃ 212.246 g/mol 125-40-6 125-40-6 Neuroprotective Agents; Anticonvulsants; Anesthetics; Central Nervous System Agents; ATC:N07XX02 For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)s
Oxyphencyclimin C₂₀H₂₈N₂O₃ 344.448 g/mol 125-53-1 125-53-1 Antineoplastic Agents; ATC:V10XX02 For treatment of non-Hodgkin's lymphomas
Pyruvinsäure C₃H₄O₃ 88.063 g/mol 127-17-3 127-17-3 Anti-Anxiety Agents; GABA Modulators; Hypnotics and Sedatives; ATC:N05CD01 For short-term and intermittent use in patients with recurring insomnia and poor sleeping habitss
Trimethadion C₆H₉NO₃ 143.141 g/mol 127-48-0 127-48-0 Thermolysin inhibitor Not Availables
Sulfisoxazol C₁₁H₁₃N₃O₃S 267.305 g/mol 127-69-5 127-69-5 Antineoplastic Agents; Protease Inhibitors; ATC:L01XX32 For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies.s
n-Ethylmaleimid C₆H₇N₁O₂ 125.127 g/mol 128-53-0 128-53-0 Antifungals; ATC:J02AX04 For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.s
Inosininsäure C₁₀H₁₃N₄O₈P₁ 348.208 g/mol 131-99-7 131-99-7 Anti-migraine Agents; Anti-inflammatory Agents; Vasoconstrictor Agents; Selective Serotonin Agonists; ATC:N02CC05 For the treatment of acute migraine headache in adultss
Dexbrompheniramin C₁₆H₁₉BrN₂ 319.24 g/mol 132-21-8 132-21-8 Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AH03 For the treatment of osteoarthritis and dysmenorrhoeas
Chlorprocain C₁₃H₁₉ClN₂O₂ 270.755 g/mol 133-16-4 133-16-4 Bile säure sequestrants; ATC:C10AC04 For use, alone or in combination with an HMG-CoA reductase inhibitor, as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in patients with primary hypercholesterolemia (Fredrickson Type IIa).s
Diethylpropion C₁₃H₁₉NO 205.296 g/mol 134-80-5 134-80-5 Anti-Testosterone Agents; Antineoplastic Agents For palliative treatment of advanced prostate cancers
Tetrahydrofolinsäure C₁₉H₂₃N₇O₆ 445.434 g/mol 135-16-0 135-16-0 Adrenergic beta-Agonists; Tocolytic Agents; Bronchodilator Agents; ATC:R03AC For relief and prevention of bronchospasm due to asthma; Emphysema; Chronic bronchitiss
Trimethobenzamid C₂₁H₂₈N₂O₅ 388.458 g/mol 138-56-7 138-56-7 Cytochrome P450Epok inhibitor Not Availables
Ricinoleinsäure C₁₈H₃₄O₃ 298.465 g/mol 141-22-0 141-22-0 Antiemetics; Antivertigo Agents For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.s
Dicarboxylinsäure c3; propanediolinsäure;metahnedicarboxylinsäure C₃H₄O₄ 104.062 g/mol 141-82-2 141-82-2 Antihypertensive Agents; Alpha-adrenergic Blocking Agents; ATC:C02CA01 For treatment of hypertension and chronic heart failure.s
Glyceraldehyd-3-phosphat C₃H₇O₆P₁ 170.058 g/mol 142-10-9 142-10-9 Antineoplastic Agents For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)s
Dodecanoinsäure C₁₂H₂₄O₂ 200.320 g/mol 143-07-7 143-07-7 DNA Primase/Helicase inhibitor Not Availables
Anileridin C₂₂H₂₈N₂O₂ 352.47 g/mol 144-14-9 144-14-9 Antitrichomonal Agents; Anti-Infectives; Antiprotozoals; ATC:J01XD02; ATC:P01AB02 For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age.s
Sulfoxon C₁₄H₁₆N₂O₆S₃ 404.485 g/mol 144-75-2 144-75-2 In process For the treatment of insomnia characterized by difficulty with sleep onset.s
Sulfacetamid C₈H₁₀N₂O₃S 214.243 g/mol 144-80-9 144-80-9 Analgesics; Psychotropic Drugs; Hallucinogens; Antiemetics; ATC:A04AD10 For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatmentss
Sulfamethizol C₉H₁₀N₄O₂S₂ 270.333 g/mol 144-82-1 144-82-1 Antipsychotics; Dopamine Antagonists; ATC:N05AH01 For the management of the manifestations of psychotic disorderss
Sulfapyridin C₁₁H₁₁N₃O₂S 249.29 g/mol 144-83-2 144-83-2 Antidepressants, Second-Generation; Anti-anxiety Agents; Serotonin Uptake Inhibitors; ATC:N06AX05 For the treatment of depression.s
Flavin-adenin-dinucleotid C₂₇H₃₃N₉O₁₅P₂ 785.557 g/mol 146-14-5 146-14-5 Antineoplastic Agents; Antiviral Agents; Immunomodulatory Agents For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcomas
Riboflavinmonophosphat C₁₇H₂₁N₄O₉P₁ 456.348 g/mol 146-17-8 146-17-8 Antihistamines; ATC:R06AD04 Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorderss
Guanosin-5-diphosphat C₁₀H₁₅N₅O₁₁P₂ 443.203 g/mol 146-91-8 146-91-8 Anti-HIV Agents; Protease Inhibitors; ATC:J05AE08 For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection.s
Levallorphan C₁₉H₂₅NO 283.408 g/mol 152-02-3 152-02-3 Bifunctional Deaminase/Diphosphatase inhibitor Not Availables
Sulfametopyrazin C₁₁H₁₂N₄O₃S 280.304 g/mol 152-47-6 152-47-6 Daptomycin inhibitor Not Availables
Dydrogesteron C₂₁H₂₈O₂ 312.446 g/mol 152-62-5 152-62-5 Antineoplastic Agents For treatment of metastatic colorectal cancers
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside C₂₇H₃₀O₁₆ 610.524 g/mol 153-18-4 153-18-4 Analgesics, Opioid; Narcotic Antagonists; Narcotics; ATC:N02AF02 For the relief of moderate to severe pain.s
Cephalothin C₁₆H₁₆N₂O₆S₂ 396.44 g/mol 153-61-7 153-61-7 Anti-Dyskinesia Agents; Antipsychotic Agents; Dopamine Antagonists; ATC:N05AG02 Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.s
000003-[[acetoxymethyl-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylsäure]] C₁₆H₁₆N₂O₆S₂ 396.432 g/mol 153-61-7 153-61-7 Chondroitinase Ac inhibitor Not Availables
Methscopolamin C₁₈H₂₄NO₄ 318.387 g/mol 155-41-9 155-41-9 Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AE12 Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.s
Decamethonium C₁₆H₃₈N₂ 258.486 g/mol 156-74-1 156-74-1 Central Nervous System Stimulants; ATC:N06BA05 For treatment of Attention Deficit Hyperactivity Disorder (ADHD)s
Ethynodioldiacetat C₂₄H₃₂O₄ 384.508 g/mol 297-76-7 297-76-7 Anesthetics, Local; ATC:N01BB01; ATC:N01BB10 For the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.s
Propanthelin C₂₃H₃₀NO₃ 368.489 g/mol 298-50-0 298-50-0 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AE03; ATC:M01AE17; ATC:M02AA10 For the treatment of pain (muscular and rheumatic), sprains, strains, backache and neuralgia and for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis.s
Cinnarizin C₂₆H₂₈N₂ 368.514 g/mol 298-57-7 298-57-7 Antihypertensive Agents Used to treat and control hypertension.s
3,5-Diiodtyrosin C₉H₉N₁O₃I₂ 432.984 g/mol 300-39-0 300-39-0 Antithyroid Agents; ATC:H03BB01 For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.s
Retinoinsäure C₂₀H₂₈O₂ 300.440 g/mol 302-79-4 302-79-4 Immunomodulatory Agents; Immunosuppresants For treatment of moderate to severe chronic plaque psoriasiss
Cyclobenzaprin C₂₀H₂₁N 275.387 g/mol 303-53-7 303-53-7 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:N02BA11 For acute or long-term use for symptomatic treatment of mild to moderate pain, osteoarthritis, and rheumatoid arthritis.s
Hexafluoreniumbromid C₃₆H₄₂N₂+₂ 502.732 g/mol 317-52-2 317-52-2 Methionine Aminopeptidase inhibitor Not Availables
Propionyl-coenzym-A C₂₄H₄₁N₇O₁₇P₃S₁ 824.606 g/mol 317-66-8 317-66-8 Anti-Bacterial Agents; ATC:J01XX01 For the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis.s
Isocitrinsäure C₆H₈O₇ 192.125 g/mol 320-77-4 320-77-4 Antibiotics; Antineoplastic Agents; ATC:L01DB01 For the treatment of Koposi's sarcome connected to AIDS.s
4-Nitrophenylphosphat C₆H₆N₁O₆P₁ 219.090 g/mol 330-13-2 330-13-2 Anti-Anxiety Agents; Anticonvulsants; GABA Modulators; ATC:N05BA05 For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal.s
Decanoinsäure C₁₀H₂₀O₂ 172.267 g/mol 334-48-5 334-48-5 Antispasmodics; Anti-Incontinence Agents; ATC:G04BD08 For the treatment of micturition frequency/polyuria.s
Fluocinonid C₂₆H₃₂F₂O₇ 494.525 g/mol 356-12-7 356-12-7 Antihypertensive Agents; ATC:C02AA01 For the treatment of hypertensions
Propiomazin C₂₀H₂₄N₂OS 340.483 g/mol 362-29-8 362-29-8 Antilipemic Agents; Fribic säure Derivatives; ATC:C10AB04 For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.s
Thymidin-5-phosphat C₁₀H₁₅N₂O₈P₁ 322.211 g/mol 365-07-1 365-07-1 In process For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).s
Desoximetason C₂₂H₂₉FO₄ 376.462 g/mol 382-67-2 382-67-2 Antihypertensive Agents; Diuretics, Sulfamyl; ATC:C03BA11 For the treatment of hypertension, alone or in combination with other antihypertensive drugs as well as for the treatment of salt and fluid retention associated with congestive heart failure or edema from pregnancy.s
Methoxamin C₁₁H₁₇NO₃ 211.258 g/mol 390-28-3 390-28-3 Antipsychotics; Thioxanthenes; Dopamine Antagonists For use in schizophrenia and depressions
Fluormetholon C₂₂H₂₉FO₄ 376.462 g/mol 426-13-1 426-13-1 Anesthetics; ATC:N01BB10 For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain managements
5,7-Dihydroxy-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one; 4',5,7-Trihydroxyisoflavon; Prunetol; Genisteol C₁₅H₁₀O₅ 270.241 g/mol 446-72-0 446-72-0 Anti-ulcer Agents; Antimuscarinics; Antispasmodics; ATC:A02BX03 For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.s
Pyridoxin-5-phosphat C₈H₁₂N₁O₆P₁ 249.160 g/mol 447-05-2 447-05-2 Cytochrome C Peroxidase inhibitor Not Availables
Ethoxzolamid C₉H₁₀N₂O₃S₂ 258.319 g/mol 452-35-7 452-35-7 Dopamine Agents; Antiparkinson Agents; Antidyskinetics; ATC:N04BA For treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonisms
000004-methyl-1,2-benzendiol C₇H₈O₂ 124.139 g/mol 452-86-8 452-86-8 Anti-Anxiety Agents; Adjuvants, Anesthesia; GABA Modulators; Benzodiazepines; ATC:N05CD05 For the short-term treatment of insomnia.s
(3-Carboxy-2-(r)-hydroxy-propyl)-trimethyl-ammonium C₇H₁₆N₁O₃₁+ 610.192 g/mol 461-06-3 461-06-3 Antihypermagnesemic; Antihypocalcemic; Electrolyte replenisher; Nutritional supplement, mineral For treatment of mild hypocalcemia due to neonatal tetany, tetany due to parathyroid deficiency or vitamin D deficiency, and alkalosis, as prophylaxis of hypocalcemia during exchange transfusions, in the treatment of intestinal malabsorption, and to replenish electrolytes.s
Dihydrolipoinsäure C₈H₁₆O₂S₂ 208.333 g/mol 462-20-4 462-20-4 Hypoglycemic Agents; ATC:A10BB07 For use as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with non-insulin-dependent diabetes mellitus (NIDDM; type II), formerly known as maturity-onset diabetes, after an adequate trial of dietary therapy has proved unsatisfactory.s
Propoxyphen C₂₂H₂₉NO₂ 339.471 g/mol 469-62-5 469-62-5 Antineoplastic Agents; ATC:L01CB02 Treatment of refractory acute lymphoblastic leukaemias
2,4-Dihydroxy-3,3-dimethyl-butyrat C₆H₁₁O₄₁- 739.128 g/mol 470-29-1 470-29-1 Isocitrate Lyase inhibitor Not Availables
Oxaminsäure C₂H₃N₁O₃ 89.051 g/mol 471-47-6 471-47-6 Analgesics; Antimanic Agents; Anticonvulsants; ATC:N03AF01 For the treatment of epilepsy and pain associated with true trigeminal neuralgia.s
n-Cholylglycin C₂₆H₄₃N₁O₆ 465.629 g/mol 475-31-0 475-31-0 Anti-ulcer Agents; Antimuscarinics; Antispasmodics; ATC:A03AB05 For the treatment of enuresis.s
Podofilox C₂₂H₂₂O₈ 414.405 g/mol 477-47-4 477-47-4 anti-emetics; antivertigo ATC:N07CA02 For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.s
Dyphyllin C₁₀H₁₄N₄O₄ 254.243 g/mol 479-18-5 479-18-5 Antineoplastic Agents; Pigmenting Agents; ATC:D05AD02; ATC:D05BA02 For the treatment of psoriasis and vitiligos
Chlorophyll A C₅₅H₇₂N₄O₅Mg₁ 893.503 g/mol 479-61-8 479-61-8 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Carbinoxamin C₁₆H₁₉ClN₂O 290.788 g/mol 486-16-8 486-16-8 Adrenergic Agents; Dopamine Agents; Dopamine Uptake Inhibitors; Adrenergic Uptake Inhibitors; Central Nervous System Stimulants; Amphetamines; Sympathomimetics; ATC:N06BA01 For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.s
3-Methylbenzol-1,2-diol C₇H₈O₂ 124.139 g/mol 488-17-5 488-17-5 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalance.s
Canalin C₄H₁₀N₂O₃ 134.135 g/mol 496-93-5 496-93-5 Keratolytic Agents; Antineoplastic Agents; Cell Stimulants and Proliferants (84:16.00); ATC:D10AD01; ATC:D10AD04; ATC:D10BA01; ATC:L01XX14; ATC:L01XX22 For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.s
Proparacain C₁₆H₂₆N₂O₃ 294.389 g/mol 499-67-2 499-67-2 Antidepressive Agents, Tricyclic; Serotonin Uptake Inhibitors; ATC:N06AA04 For the treatment of depression, obsessive compulsive disorder (OCD), panic attacks with or without agoraphobia, narcolepsy, chronic pain, and enuresis.s
Masoprocol C₁₈H₂₂O₄ 302.365 g/mol 500-38-9 500-38-9 Tranquilizing Agents; Muscle Relaxants; Antidepressive Agents, Tricyclic; Skeletal Muscle Relaxants; ATC:M03BX08 For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.s
Isovalerinsäure C₅H₁₀O₂ 102.133 g/mol 503-74-2 503-74-2 Antidotes; Chelating Agents; ATC:V09CA02; ATC:V09IA03 For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 µg/dL. May also be used to treat mercury or arsenic poisoning.s
12-Hydroxydodecanoinsäure C₁₂H₂₄O₃ 216.320 g/mol 505-95-3 505-95-3 Antineoplastic Agents; ATC:L01AA02 For treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's diseases
Chlorophyll-B C₅₅H₇₀N₄O₆Mg₁ 907.486 g/mol 519-62-0 519-62-0 Central Nervous System Stimulants; Respiratory System Agents; ATC:R07AB01 For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.s
Dromostanolon C₂₃H₃₆O₃ 360.53 g/mol 521-12-0 521-12-0 Antinematodal Agents; ATC:P02CA01 For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.s
Malonylcoenzym-a C₂₄H₃₈N₇O₁₉P₃S₁ 853.581 g/mol 524-14-1 524-14-1 Cardiotonic Agents; Bronchodilator Agents; Respiratory Smooth Muscle Relaxants; ATC:R03DA05 For the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis.s
Isoetharin C₁₃H₂₁NO₃ 239.311 g/mol 530-08-5 530-08-5 Propionyl-Coa Carboxylase Complex B Subunit inhibitor Not Availables
Thiaminphosphat C₁₂H₁₇N₄O₄P₁S₁ 344.324 g/mol 532-40-1 532-40-1 Anti-Arrhythmia Agents Used to treat irregular heartbeats (arrhythmias) and maintain a normal heart rate.s
Hexylcain C₁₆H₂₃NO₂ 261.359 g/mol 532-77-4 532-77-4 Antimetabolites, Antineoplastic; Enzyme Inhibitors For treatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia.s
Hydroxystilbamidineisethionat C₁₈H₂₂N₄O₅S 406.457 g/mol 533-22-2 533-22-2 Probable Methylisocitrate Lyase inhibitor Not Availables
Acetohydroxaminsäure C₂H₅N₁O₂ 75.067 g/mol 546-88-3 546-88-3 Chondroitinase Ac inhibitor; Chondroitinase B inhibitor Not Availables
2-Amino-3-hydroxybenzoesäure C₇H₇N₁O₃ 153.137 g/mol 548-93-6 548-93-6 Anti-bacterial Agents; Aminoglycosides; ATC:J01GB01; ATC:S01AA12 For the treatment of pseudomonas aeruginosa lung infectionss
Purinribosid C₁₀H₁₃N₄O₄₁+ 845.215 g/mol 550-33-4 550-33-4 Acylamino-säure-Releasing Enzyme inhibitor Not Availables
4,7-Dihydroxyisoflavon; 7-o-b-d-glucopyranosid C₂₁H₂₀O₉ 416.384 g/mol 552-66-9 552-66-9 Photoactive Yellow Protein inhibitor Not Availables
Methazolamid C₅H₈N₄O₃S₂ 236.274 g/mol 554-57-4 554-57-4 Lipoxygenase-3 inhibitor Not Availables
Chlortrianisen C₂₃H₂₁ClO₃ 380.864 g/mol 569-57-3 569-57-3 Daptomycin inhibitor Not Availables
Meclizin C₂₅H₂₇ClN₂ 390.948 g/mol 569-65-3 569-65-3 Antineoplastic Agents, Phytogenic; Nucleic säure Synthesis Inhibitors; ATC:L01CB01 For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.s
Artigenin-congener; Dibenzylbutyrolactonlignanolid C₂₀H₂₃O₆ 359.398 g/mol 580-72-3 580-72-3 Osmotic Agents Used for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.s
5,6-Dimethylbenzimidazol C₉H₁₀N₂ 146.191 g/mol 582-60-5 582-60-5 Peptide inhibitor Not Availables
2-Oxobutanonsäure C₄H₆O₃ 102.090 g/mol 600-18-0 600-18-0 Ferric Hydroxamate Receptor inhibitor Not Availables
Auccinylcoenzym A C₂₅H₄₀N₇O₁₉P₃S₁ 867.608 g/mol 604-98-8 604-98-8 Tetrameric Beta-Beta-Alpha Mini-Protein inhibitor Not Availables
Benzoylforminsäure C₈H₆O₃ 150.134 g/mol 611-73-4 611-73-4 Anti-Allergic Agents; Antipruritics; Histamine H1 Antagonists; ATC:R06AX17; ATC:S01GX08 Indicated as an add-on or prophylactic oral medication in the chronic treatment of mild atopic asthmatic children. Also for the temporary prevention of itching of the eye due to allergic conjunctivitis (ophthalmic).s
Meclofenamat C₁₄H₁₁Cl₂NO₂ 295.02 g/mol 644-62-2 644-62-2 Anti-Bacterial Agents Not Availables
Metyrosin C₁₀H₁₃NO₃ 195.215 g/mol 672-87-7 672-87-7 Beta-Lactamase Ctx-M-9 inhibitor Not Availables
Chloroxin C₉H₅Cl₂NO 214.048 g/mol 773-76-2 773-76-2 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AC01; ATC:M02AA07; ATC:S01BC06 For treatment of osteoarthritis and rheumatoid arthritis.s
Haloprogin C₉H₄Cl₃IO 361.39 g/mol 777-11-7 777-11-7 Antiemetics; Prokinetic Agents; Dopamine Antagonists; ATC:A03FA01 For the treatment of gastroesophageal reflux disease (GERD)s
Desoxycorticosteronpivalat C₂₆H₃₈O₄ 414.578 g/mol 808-48-0 808-48-0 Antihypertensive Agents; Diuretics, Thiazide; Vasodilator Agents; ATC:C02DA01; ATC:V03AH01 Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma.s
2-Deoxyguanosin-5-monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol 902-04-5 902-04-5 Antiviral Agents; ATC:J05AB04 For the treatment of chronic hepatitis C and for respiratory syncytial virus (RSV).s
2-Deoxycytidin C₉H₁₃N₃O₄ 227.219 g/mol 951-77-9 951-77-9 Enzyme replacement; ATC: A16AB01 For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)s
2'-Deoxyuridin C₉H₁₂N₂O₅ 228.204 g/mol 951-78-0 951-78-0 Bifunctional P-450: Nadph-P450 Reductase inhibitor Not Availables
Acetohexamid C₁₅H₂₀N₂O₄S 324.396 g/mol 968-81-0 968-81-0 Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Enzyme Inhibitors; ATC:C05BA04 For the relief of bladder pain or discomfort associated with interstitial cystitis.s
Testolacton C₁₉H₂₄O₃ 300.392 g/mol 968-93-4 968-93-4 Sympatholytics; Antihypertensive Agents; Antiarrhythmic Agents; Adrenergic Agents; ATC:C07AB02; ATC:C07AB52 For the treatment of hypertension and angina pectoris.s
S-Adenosyl-l-homocystein C₁₄H₂₀N₆O₅S₁ 384.409 g/mol 979-92-0 979-92-0 Antiarrhythmic Agents; ATC:C01BA03 For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.s
Nafcillin C₂₁H₂₂N₂O₅S 414.476 g/mol 985-16-0 985-16-0 Anti-bacterial Agents; Aminoglycosides; ATC:D06AX12; ATC:J01GB06; ATC:S01AA21 For short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter (Mima-Herellea) species.s
Lymecyclin C₂₂H₂₃ClN₂O₈ 478.879 g/mol 992-21-2 992-21-2 Antineoplastic Agents; Immunosuppressive Agents; ATC:L01AA06 For third line chemotherapy of germ cell testicular cancer. It should ordinarily be used in combination with a prophylactic agent for hemorrhagic cystitis, such as mesna.s

1000 .. 10000

2-Deoxycytidin-5-monophosphat C₉H₁₄N₃O₇P₁ 307.199 g/mol 1032-65-1 1032-65-1 Corticosteroid; Glucocorticoids; Anti-inflammatory,
o-Phosphoethanolamin C₃H₁₀N₁O₅P₁ 171.089 g/mol 1071-23-4 1071-23-4 Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cyclooxygenase Inhibitors; ATC:M01AB02 For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis. ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis.s
7,8-dimethylalloxazin; 6,7-dimethylalloxazin C₁₂H₁₀N₄O₂ 242.237 g/mol 1086-80-2 1086-80-2 Vasodilator Agents; Antihypertensive Agents; ATC:C02DC01; ATC:D11AX01 For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.s
Ethopropazin C₁₉H₂₄N₂S 312.473 g/mol 1094-08-2 1094-08-2 Abortifacient Agents, Nonsteroidal; Oxytocics; Diagnostic aid (angiography); Uterine stimulants; ATC:G02AD01 Used for aborting second-trimester pregnancy (between the twelfth to eighteenth week of gestation) and in incomplete abortion or for therapeutic abortion in cases of intrauterine fetal death and congenital abnormalities incompatible with life. Also used at low-doses for medically indicated induction of labor at term. Also injected intra-arterially for use as a vasodilator to assist in angiography.s
amylotrios C₁₈H₃₂O₁₆ 504.441 g/mol 1109-28-0 1109-28-0 Cellobiohydrolase II inhibitor Not Availables
000003-hydroxypyruvinsäure C₃H₄O₄ 104.062 g/mol 1113-60-6 1113-60-6 Anti-Infective Agents; Enzyme Inhibitors; ATC:J01MB02 For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species.s
000003-sulfinoalanin C₃H₇N₁O₄S₁ 153.153 g/mol 1115-65-7 1115-65-7 Adrenergic alpha-Agonists; Sympathomimetics; Vasoconstrictor Agents; ATC:C01CA10 Indicated for the treatment and management of hypotension.s
biphenyl-2,3-diol C₁₂H₁₀O₂ 186.210 g/mol 1133-63-7 1133-63-7 Vasodilator Agents; Antihypertensive Agents; ATC:C08CA08; Calcium Channel Blockers; For the treatment of mild to moderate hypertensions
Clomocyclin C₂₃H₂₅ClN₂O₉ 508.905 g/mol 1181-54-0 1181-54-0 Antivirals; ATC:D06BB06; ATC:J05AB13 Used to treat recurrent cold sores on the lips and face.s
n-Acetyl-l-glutamat C₇H₁₁N₁O₅ 189.168 g/mol 1188-37-0 1188-37-0 DNA Gyrase Subunit B inhibitor Not Availables
Sotradecol C₁₄H₃₀O₄S 294.452 g/mol 1191-50-0 1191-50-0 Anti-Infective Agents For the treatment of Bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patientss
Tranexaminsäure C₈H₁₅NO₂ 157.21 g/mol 1197-18-8 1197-18-8 Dihydrofolate Reductase inhibitor Not Availables
Bentoquatam Not Available Not Available 1340-69-8 1340-69-8 Anti-Asthmatic Agents; Antiarrhythmic Agents; Bronchodilator Agents; Anti-Inflammatory Agents, Non-Steroidal Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.s
Cryptenamin C₂₈H₄₆₀₁₀N Not Available 1356-18-9 1356-18-9 Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AB08 For acute and long-term use in the management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.s
Polymyxin B Sulfat C₅₅H₉₅N₁₆O₁₃R.(H₂O₄S)x Not Available 1405-20-5 1405-20-5 Sympatholytics; Antihypertensive Agents; Anti-Arrhythmia Agents; Adrenergic beta-Antagonists; ATC:C07AA12 Used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension.s
acetoacetyl-coenzyme a C₂₅H₄₀N₇O₁₈P₃S₁ 851.608 g/mol 1420-36-6 1420-36-6 Immunosuppressive Agents; Antineoplastic Agents; ATC:L01BB04 For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.s
Thiethylperazin C₂₂H₂₉N₃S₂ 399.618 g/mol 1420-55-9 1420-55-9 Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; ATC:M01AX01 For acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.s
Flurandrenolid C₂₄H₃₃FO₆ 436.514 g/mol 1524-88-5 1524-88-5 Anesthetics; Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N01AH01; ATC:N02AB03 For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy.s
Metaxalon C₁₂H₁₅NO₃ 221.252 g/mol 1665-48-1 1665-48-1 Estrogens; ATC:G03CA57 For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)s
Homolinoleninsäure C₂₀H₃₄O₂ 306.487 g/mol 1783-84-2 1783-84-2 Radiation-Sensitizing Agents; Anti-Infectives; Antiprotozoals; ATC:A01AB17; ATC:D06BX01; ATC:G01AF01; ATC:J01XD01; ATC:P01AB01 Treatment of acute acne rosaceas
d-Aspartamsäure C₄H₇N₁O₄ 133.104 g/mol 1783-96-6 1783-96-6 Estrogen Receptor Beta inhibitor Not Availables
Bromdiphenhydramin C₁₇H₂₀BrNO 334.251 g/mol 1808-12-4 1808-12-4 Antimetabolites; Antimetabolites, Antineoplastic; Antirheumatic Agents; Immunosuppressive Agents; ATC:L04AX01 For use as an adjunct in the prevention of rejection in renal homotransplantation. Also for the management of severe, active rheumatoid arthritis unresponsive to rest, aspirin or other nonsteroidal anti-inflammatory drugs, or to agents in the class of which gold is an example.s
2-Deoxyadenosin-5-triphosphat C₁₀H₁₆N₅O₁₂P₃ 491.184 g/mol 1927-31-7 1927-31-7 Ornithine Decarboxylase inhibitor Not Availables
Methdilazin C₁₈H₂₀N₂S 296.431 g/mol 1982-37-2 1982-37-2 Serotonin reuptake inhibitor; Anorexigenic Agents; Stimulants; ATC:A08AA02; ATC:A08AA04 For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.s
d-Mannuronsäure C₆H₁₀O₇ 194.141 g/mol 1986-14-7 1986-14-7 Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
Flumethasonpivalat C₂₇H₃₆F₂O₆ 494.568 g/mol 2002-29-1 2002-29-1 Carnitine Acetyltransferase Isoform 2 inhibitor Not Availables
2-Deoxycytidin-5-triphosphat C₉H₁₆N₃O₁₃P₃ 467.159 g/mol 2056-98-6 2056-98-6 Antinarcotic Agents; Depressants; Opiate Antagonists; ATC:V03AB15 For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.s
l-Iduroninsäure C₆H₁₀O₇ 194.141 g/mol 2073-35-0 2073-35-0 Narcotics; Antitussives; Analgesics; ATC:N02AC04; ATC:N02AC54; ATC:N02AC74 For the relief of mild to moderate pains
000003-[[bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4- dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1 dioxide]] C₁₄H₁₆N₃O₄Cl₁S₂ 389.871 g/mol 2259-96-3 2259-96-3 Sympatholytics; EENT Drugs; ATC:S01ED03 For lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertensions
Cyclothiazid C₁₄H₁₆ClN₃O₄S₂ 389.879 g/mol 2259-96-3 2259-96-3 Ileal Lipid Binding Protein inhibitor Not Availables
2'-Deoxyguanosin-5'-triphosphat 2-Deoxyguanosin-5-triphosphat C₁₀H₁₆N₅O₁₃P₃ 507.183 g/mol 2564-35-4 2564-35-4 Vasodilator Agents; Bronchodilator Agents; Respiratory Smooth Muscle Relaxants; Phosphodiesterase Inhibitors; ATC:R03DA01 For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.s
Carphenazin C₂₄H₃₁N₃O₂S 425.59 g/mol 2622-30-2 2622-30-2 Chlorophyll A-B Binding Protein Ab80 inhibitor Not Availables
Benzylpenicilloylpolylysin C₂₂H₃₁N₃O₆S Not Available 2642-55-9 2642-55-9 Chalcone-Flavonone Isomerase 1 inhibitor Not Availables
Medryson C₂₂H₃₂O₃ 344.488 g/mol 2668-66-8 2668-66-8 Antiparasitics; Scabicides; Antipruritics; Scabicides; ATC:D04A; ATC:P03AX For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.s
Flupenthixol C₂₃H₂₅F₃N₂OS 434.519 g/mol 2709-56-0 2709-56-0 Anti-allergic Agents; ATC:R06AX07 For the treatment of hay fever, urticaria (hives), and other allergic systems.s
Acetophenazin C₂₃H₂₉N₃O₂S 411.561 g/mol 2751-68-0 2751-68-0 Antihistamines; ATC:R06AA08 For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis.s
000004-nitrocatechol C₆H₅N₁O₄ 155.110 g/mol 3316-09-4 3316-09-4 Antiparkinson Agents; Muscarinic antagonists; ATC:N04AA03 Used for the symptomatic treatment of parkinsonism.s
alpha-d-Mannosid C₆H₁₂O₆ 180.157 g/mol 3458-28-4 3458-28-4 Antineoplastic Agents, Hormonal; Glucocorticoids; Antiemetics; Anti-inflammatory Agents; Adrenergic Agents; ATC:A01AC02; ATC:C05AA09; ATC:D07AB19; ATC:D07XB05; ATC:D10AA03; ATC:H02AB02; ATC:R01AD03; ATC:S01BA01; ATC:S01CB01; ATC:S02BA06; ATC:S03BA01 Injection: for the treatment of endocrine disorders, rheumatic D=disorders, collagen diseases, dermatologic diseases, allergic statesc, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema.s
Cyclacillin C₁₅H₂₃N₃O₄S 341.427 g/mol 3485-14-1 3485-14-1 Hypnotics and Sedatives; Anticonvulsants; For the treatment of Epilepsys
Hetacillin C₁₉H₂₃N₃O₄S 389.47 g/mol 3511-16-8 3511-16-8 Antibiotics, Antineoplastic; Alkylating Agents; Cross-Linking Reagents; Nucleic säure Synthesis Inhibitors; ATC:L01DC03 For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder.s
Cephaloglycin C₁₈H₁₉N₃O₆S 405.426 g/mol 3577-01-3 3577-01-3 Anticonvulsants; ATC:N03AA30 For the treatment of epilepsys
l-Rhamnose C₆H₁₂O₅ 164.158 g/mol 3615-41-6 3615-41-6 Anticonvulsants; ATC:N03AB04 For the treatment of refractory partial epilepsy.s
Azatadin C₂₀H₂₂N₂ 290.402 g/mol 3964-81-6 3964-81-6 Anti-Inflammatory Agents; ATC:A01AC03; ATC:A07EA02; ATC:C05AA01; ATC:D07AA02; ATC:D07AB02; ATC:D07AB11; ATC:D07AC16; ATC:D07XA01; ATC:H02AB09; ATC:S01BA02; ATC:S01CB03; ATC:S02BA01 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.s
Dihydrofolinsäure C₁₉H₂₁N₇O₆ 443.418 g/mol 4033-27-6 4033-27-6 Antineoplastic Agents; Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A07EA01; ATC:C05AA04; ATC:D07AA01; ATC:D07AA03; ATC:D07AC14; ATC:D07XA02; ATC:D10AA02; ATC:H02AB04; ATC:H02AB06; ATC:R01AD02; ATC:S01BA04; ATC:S01CB02; ATC:S02BA03; ATC:S03BA02 For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders.s
000005-hydroxy-l-tryptophan C₁₁H₁₁N₂O₃ 219.219 g/mol 4350-09-8 4350-09-8 Vasoconstrictor Agents; Anesthetics; Local Anesthetics; ATC:N01BC01; ATC:R02AD03; ATC:S01HA01; ATC:S02DA02 For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.s
Phosphonoacetinsäure C₂H₅O₅P₁ 140.032 g/mol 4408-78-0 4408-78-0 Antineoplastic Agents; Antimetabolites; Purine analogues; ATC:L01BB02 For remission induction and maintenance therapy of acute lymphatic leukemia.s
Trehalose-6-phosphat C₁₂H₂₃O₁₄P₁ 422.279 g/mol 4484-88-2 4484-88-2 Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Adrenergic Uptake Inhibitors; ATC:N06AA09 For the treatment of anxiety, bipolar disorders, and depression.s
Carbenicillin C₁₇H₁₈N₂O₆S 378.401 g/mol 4697-36-3 4697-36-3 Antipsychotics; Antiemetics; Dopamine Antagonists; Phenothiazines; ATC:N05AA01 For the treatment of schizophrenia, control nausea and vomiting, For relief of restlessness and apprehension before surgery, adjunct in the treatment of tetanus, control the manifestations of the manic type of manic-depressive illness.s
Metixen C₂₀H₂₃NS 309.469 g/mol 4969-02-2 4969-02-2 Anti-tocolytic Agents; Labor Induction Agents; ATC:Oxytocin To assist in labor, elective labor induction, uterine contraction inductions
Guanabenz C₈H₈Cl₂N₄ 231.081 g/mol 5051-62-7 5051-62-7 Antihypertensive Agents; Sympatholytics; ATC:C04AB01; ATC:G04BE05 For the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. Also for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision.s
beta-l-Arabinose C₅H₁₀O₅ 150.131 g/mol 5328-37-0 5328-37-0 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Fibrinolytic Agents; Anticoagulants; Salicylates; ATC:A01AD05; ATC:B01AC06; ATC:N02BA01 For use in the temporary relief of various forms of pain, inflammation associated with various conditions (including rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and ankylosing spondylitis), and is also used to reduce the risk of death and/or nonfatal myocardial infarction in patients with a previous infarction or unstable angina pectoris.s
Mesoridazin C₂₁H₂₆N₂OS₂ 386.576 g/mol 5588-33-0 5588-33-0 Antioxidants; Essential Vitamins; Free Radical Scavengers; Vitamins (Vitamin C); ATC:A11GA01 Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine säureification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.s
Methanthelin C₂₁H₂₆NO₃ 340.436 g/mol 5818-17-7 5818-17-7 Antineoplastics; antimetabolites; Antimetabolites For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means.s
d-Glutamin C₅H₁₀N₂O₃ 146.146 g/mol 5959-95-5 5959-95-5 Bacteriorhodopsin inhibitor Not Availables
Perhexilin C₁₉H₃₅N 277.488 g/mol 6621-47-2 6621-47-2 Nrh Dehydrogenase [Quinone] 2 inhibitor Not Availables
Echothiophate Iodid C₉H₂₃INO₃PS 383.228 g/mol 6736-03-4 6736-03-4 Enzyme replacement For the treatment of mucopolysaccharidosiss
d-Glutaminsäure C₅H₉N₁O₄ 147.130 g/mol 6893-26-1 6893-26-1 Prostaglandin H2 Synthase-1 inhibitor Not Availables
Clidinium C₂₂H₂₆NO₃ 352.447 g/mol 7020-55-5 7020-55-5 Antiarrhythmic Agents; ATC:C01BA02 For the treatment of life-threatening ventricular arrhythmias.s
Trimethaphan C₂₂H₂₅N₂OS 365.513 g/mol 7187-66-8 7187-66-8 Cytochrome C Peroxidase inhibitor Not Availables
N-Acetyl-D-glucosamin C₈H₁₅N₁O₆ 221.210 g/mol 7512-17-6 7512-17-6 Histamine N-Methyltransferase inhibitor Not Availables
Ambenonium C₂₈H₄₂Cl₂N₄O₂ 537.564 g/mol 7648-98-8 7648-98-8 Antihyperlipidemics; ATC:C10AX01 Used to lower high cholesterol levels in the blood.s
Alseroxylon Not Available Not Available 8001-95-4 8001-95-4 Cardiotonic Agents; Sympathomimetic; ATC:C01CA04 For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failures
Ethiodol Not Available Not Available 8008-53-5 8008-53-5 Diagnostic Aid; ATC:V04CG03 Histamine phosphate is indicated as a diagnostic aid for evaluation of gastric säure secretory function.s
Ergoloidmesylat C₃₃H₄₅N₅O₅ 591.741 g/mol 8067-24-1 8067-24-1 Analgesics, Non-Narcotic; Cardiotonic Agents; Cholinergic Agonists; Miotics; ATC:N07AB01; ATC:S01EB02 Primarily used in the treatment of glaucoma, but is also used during ophthalmic surgery.s
Colistimethat C₅₈H₁₀₅N₁₆Na₅O₂₈S₅ 1749.82 g/mol 8068-28-8 8068-28-8 Acetylcholinesterase inhibitor Not Availables
Collagenase C₅₀₂₈H₇₆₆₆N₁₃₀₀O₁₅₆₄S₂₁ 112023.2 9001-12-1 9001-12-1 Corticosteroids, topical; ATC:D07AC11 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.s
Coagulation factor VIIa C₁₉₇₂H₃₀₇₆N₅₆₀O₅₉₇S₂₈ 45079.1 9001-25-6 9001-25-6 Anti-Anxiety Agents; Antiemetics; ATC:A04AD11 Used for the control of nausea and vomiting, caused by chemotherapeutic agents used in the treatment of cancer, in patients who have failed to respond adequately to conventional antiemetic treatments.s
Factor IX C₂₀₄₁H₃₁₃₆N₅₅₈O₆₄₁S₂₅ 46548.2 9001-28-9 9001-28-9 Anti-inflammatory Agents; Analgesics; Nonsteroidal Antiinflammatory Agents (NSAIDs); Carbonic Anhydrase Inhibitors; Cyclooxygenase Inhibitors; ATC:M01AE09; ATC:M02AA19; ATC:S01BC04 Flurbiprofen tablets are indicated for the acute or long-term treatment of the signs and symptoms of rheumatoid arthritis and osteorarthritis.s
Dornase alfa (Dnase) C₁₃₂₁H₁₉₉₉N₃₃₉O₃₉₆S₉ 29253.9 9003-98-9 9003-98-9 Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 For the treatment of mild to moderate active Crohn's disease.s
Eisendextran (FeO.OH.₂H₂O)₄₇₈ (Dx.COOH)₉ ~105,000 g/mol 9004-66-4 9004-66-4 Methylmalonyl-Coa Carboxyltransferase 12S Su inhibitor Not Availables
Ardeparin (C₂₆H₄₀N₂O₃₆S₅)n 1134.93 g/mol 9005-49-6 9005-49-6 Chlorophyll A-B Binding Protein, Chloroplast inhibitor Not Availables
Pegademase bovine C₁₈₂₁H₂₈₃₄N₄₈₄O₅₅₂S₁₄ 40788.2 9026-93-1 9026-93-1 Anabolic Agents; Antineoplastic Agents, Hormonal For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.s
Alpha-1-proteinase inhibitor C₂₀₀₁H₃₁₃₀N₅₁₄O₆₀₁S₁₀ 44324.5 9041-92-3 9041-92-3 Antiemetics; Histamine H1 Antagonists Used for treating vertigo, motion sickness, and nausea associated with pregnancy.s
Chymostatin C₃₁H₄₂N₇O₆₁+ 1488.683 g/mol 9076-44-2 9076-44-2 Vasodilator Agents; Anti-anxiety Agents; Antihypertensive Agents; Antiarrhythmic Agents; Adrenergic Agents; ATC:C07AA05 For the prophylaxis of migraine.s

10000 .. 100000

Glyburid C₂₃H₂₈ClN₃O₅S 494.004 g/mol 10238-21-8 10238-21-8 Antineoplastic Agents; ATC:L01XX23 For treatment of inoperable adrenocortical tumours; Cushing's syndromes
D-Milchsäure C₃H₆O₃ 90.079 g/mol 10326-41-7 10326-41-7 Alpha-Glucosidase inhibitor Not Availables
Icosapent C₂₀H₃₀O₂ 302.456 g/mol 10417-94-4 10417-94-4 Bronchodilator Agents; Adrenergic beta-Agonists For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.s
Clodronat CH₄Cl₂O₆P₂ 244.892 g/mol 10596-23-3 10596-23-3 Immunosuppressive Agents; Antifungals; ATC:L04AA10 For the prophylaxis of organ rejection in patients receiving renal transplants.s
Gadobenatdimeglumin Not Available Not Available 12700-20-8 12700-20-8 Antitubercular Agents; Leprostatic Agents; ATC:J04AD03 For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.s
000002-((formyl-hydroxy-amino)-methyl)-heptanoic säure (1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl)-amide C₁₉H₃₅N₃O₅ 385.503 g/mol 13434-13-4 13434-13-4 Acetylcholine-Binding Protein inhibitor Not Availables
Gentian Violet C₂₅H₃₀N₃+ 372.526 g/mol 14426-25-6 14426-25-6 Dietary supplement; Micronutrient; ATC:A11HA02 For nutritional supplementation and for treating dietary shortage or imbalances
Flavoxat C₂₄H₂₅NO₄ 391.46 g/mol 15301-69-6 15301-69-6 Anti-Arrhythmia Agents; ATC:C01BC03 Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.s
Cromolyn C₂₃H₁₆O₁₁ 468.367 g/mol 16110-51-3 16110-51-3 Macrophage Metalloelastase inhibitor Not Availables
Desmopressinacetat C₆₈H₁₀₂N₂₂O₂₀S₂ 1611.8 16679-58-6 16679-58-6 Adjuvants, Anesthesia; Antiemetics; Antipsychotic Agents; Dopamine Antagonists; ATC:N01AX01; ATC:N05AD08 Used to produce tranquilization and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures.s
Cerulenin C₁₂H₁₇NO₃ 223.268 g/mol 17397-89-6 17397-89-6 Phenazine Biosynthesis Protein Phzf inhibitor Not Availables
L-Norgestrel C₂₁H₂₈O₂ 312.446 g/mol 17489-40-6 17489-40-6 Antidepressants, Second-Generation; Selective Serotonin Reuptake Inhibitors (SSRIs); ATC:N06AB03 For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.s
Deslanosid C₄₇H₇₄O₁₉ 943.079 g/mol 17598-65-1 17598-65-1 Tocolytic Agents; Vasodilator Agents; Nitrates and Nitrites; ATC:C01DA02 For the prevention of anginas
Tetraphenylphosphonium C₂₄H₂₀P₁₁+ 649.133 g/mol 18198-39-5 18198-39-5 Adenosine Deaminase inhibitor Not Availables
Adenosin-5-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol 20398-34-9 20398-34-9 Diagnostic aid; gastric function; ATC:V04CG04 Used as a diagnostic aid for evaluation of gastric säure secretory functions
Oxaprozin C₁₈H₁₅NO₃ 293.317 g/mol 21256-18-8 21256-18-8 Antiparasitics For the treatment of diarrhea in adults and children caused by the protozoa Giardia lamblia; For the treatment of diarrhea in children caused by the protozoa Cryptosporidium parvums
Cephapirin C₁₇H₁₇N₃O₆S₂ 423.466 g/mol 21593-23-7 21593-23-7 Hypnotics and Sedatives Insomnias
Guanadrelsulfat C₁₀H₁₉N₃O₂ 213.277 g/mol 22195-34-2 22195-34-2 Transthyretin inhibitor Not Availables
Metipranolol C₁₇H₂₇NO₄ 309.401 g/mol 22664-55-7 22664-55-7 Anti-Bacterial Agents; Protein Synthesis Inhibitors; ATC:D06AX02; ATC:D10AF03; ATC:G01AA05; ATC:J01BA01; ATC:S01AA01; ATC:S02AA01; ATC:S03AA08 Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.s
Minaprin C₁₇H₂₂N₄O 298.383 g/mol 25905-77-5 25905-77-5 Tailspike Protein inhibitor Not Availables
Tolmetin C₁₅H₁₅NO₃ 257.285 g/mol 26171-23-3 26171-23-3 Antineoplastic Agents; Estrogens, Non-Steroidal; ATC:G03CA06 Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.s
Ritodrin C₁₇H₂₁NO₃ 287.354 g/mol 26652-09-5 26652-09-5 Anti-allergic Agents; Antiemetics; Antihistamines For the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.s
Levobupivacain C₁₈H₂₈N₂O 288.428 g/mol 27262-47-1 27262-47-1 Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N02AB Used to control moderate to severe pain.s
Calciumgluceptat C₁₄H₂₆CaO₁₆ 490.0848 g/mol 29039-00-7 29039-00-7 Nuclear Receptor Ror-Alpha inhibitor Not Availables
Glipizid C₂₁H₂₇N₅O₄S 444.548 g/mol 29094-61-9 29094-61-9 Anti-bacterial Agents; Aminoglycosides; ATC:A07AA04; ATC:J01GA01; ATC:S01AA15 For the treatment of Tuberculosiss
Mequitazin C₂₀H₂₂N₂S 322.468 g/mol 29216-28-2 29216-28-2 Antiemetics; Miscellaneous GI drugs; ATC:A03FA03; Dopamine Antagonists For management of Dyspepsia, Heartburn, Epigastric pain, Nausea, Vomitings
Docosanol C₂₃H₄₆O₂ 354.61 g/mol 30303-65-2 30303-65-2 Antineoplastic Agents; Anabolic Agents; Androgens; ATC:G03BA02; ATC:G03BA03; ATC:G03EK01 For topical testosterone replacement therapy in males with deficiency or absence of testosterones
Bitolterolmesylat C₂₈H₃₁NO₅ 461.549 g/mol 30392-41-7 30392-41-7 Anti-anxiety Agents; Hypnotics and Sedatives; Adjuvants, Anesthesia; Benzodiazepines; GABA Modulators; ATC:N05BA02 For the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.s
Amdinocillin C₂₁H₃₃N₃O₅S 439.57 g/mol 32887-01-7 32887-01-7 Anti-inflammatory Agents; Essential Vitamin; Vitamins (Vitamin B For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.s
Methylaminolevulinat C₆H₁₁NO₃ 145.156 g/mol 33320-16-0 33320-16-0 Dietary supplement; Micronutrient; ATC:A11HA05 For nutritional supplementation, also for treating dietary shortage or imbalance.s
Clocortolon C₂₇H₃₆ClFO₅ 495.023 g/mol 34097-16-0 34097-16-0 Diuretics, Thiazide; Antihypertensive Agents; ATC:C03AA03; ATC:C03AA04 Chlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.s
Ketotifenfumarat C₁₉H₁₉NOS 309.426 g/mol 34580-14-8 34580-14-8 Ribonuclease Mc inhibitor Not Availables
Fenoprofen C₁₅H₁₄O₃ 242.27 g/mol 34597-40-5 34597-40-5 N-Acetyllactosaminide Alpha-1,3- Galactosylt inhibitor Not Availables
maltotetraose C₂₄H₄₂O₂₁ 666.583 g/mol 34612-38-9 34612-38-9 Rhizome Secoisolariciresinol Dehydrogenase inhibitor Not Availables
Norgestimat C₂₃H₃₁NO₃ 369.497 g/mol 35189-28-7 35189-28-7 Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
Bentiromid C₂₃H₂₀N₂O₅ 404.415 g/mol 37106-97-1 37106-97-1 Aminoglycoside 3'-Phosphotransferase inhibitor Not Availables
Adinazolam C₁₉H₁₈ClN₅ 351.833 g/mol 37115-32-5 37115-32-5 Dietary supplement; Micronutrient; ATC:A11 Vitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps.s
Alglucerase C₂₅₃₂H₃₈₅₄N₆₇₂O₇₁₁S₁₆ 55597.4 37228-64-1;143003-46-7 Antirheumatic Agents; Immunosuppressive Agents; Dermatologic Agents; Antimetabolites; Abortifacient Agents; Antineoplastic Agents; ATC:L01BA01; ATC:L04AX03 For the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Also for the treatment of severe psoriasis and severe, active, classical or definite rheumatoid arthritis.s
Sulindac C₂₀H₁₇FO₃S 356.412 g/mol 38194-50-2 38194-50-2 Anti-inflammatory Agents; Essential Vitamin; Vitamins (Vitamin B Complex); ATC:A11DA01 For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis.s
Dinoprosttromethamin C₂₄H₄₅NO₈ 475.616 g/mol 38562-01-5 38562-01-5 Glucose-1-Phosphate Thymidylyltransferase inhibitor Not Availables
cellotetraose C₂₄H₄₂O₂₂ 682.583 g/mol 38819-01-1 38819-01-1 Antidepressants; ATC:N06AF01 Isocarboxazid is used to treat depression, especially when the patient is excitable or suffering from phobias (fears).s
clorobiocin C₃₅H₃₇N₂O₁₁Cl₁ 697.137 g/mol 39868-96-7 39868-96-7 Vasodilator Agents; Antilipemic Agents; Vitamins (Vitamin B Complex); ATC:C04AC01; ATC:C10AD02 For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy.s
Acrosoxacin C₁₇H₁₄N₂O₃ 294.305 g/mol 40034-42-2 40034-42-2 Trypanocidal Agents; Anti-Infectives For the treatement of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.s
Pamidronat C₃H₁₁NO₇P₂ 235.07 g/mol 40391-99-9 40391-99-9 Dopamine Agents; Antiparkinson Agents; Antidyskinetics; ATC:N04BA01; ATC:N04BA04 For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.s
Suprofen C₁₄H₁₂O₃S 260.309 g/mol 40828-46-4 40828-46-4 Vasodilator Agents; Antihypertensive Agents; ATC:C04AX02 For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.s
Enprofyllin C₈H₁₀N₄O₂ 194.191 g/mol 41078-02-8 41078-02-8 Vasodilator Agents; Antihypertensive Agents; ATC:C04AB02; ATC:M02AX02 For the treatment of pulmonary artery anomaliess
Tocainid C₁₁H₁₆N₂O 192.258 g/mol 41708-72-9 41708-72-9 Adjuvants, Anesthesia; Muscarinic Antagonists; Anti-cholinergic Agents For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free säureity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.s
d-Myo-inositol-1,4-bisphosphat C₆H₁₄O₁₂P₂ 340.117 g/mol 47055-78-7 47055-78-7 Antirheumatic Agents; Gastrointestinal Agents; Anti-inflammatory Agents; Anti-Infectives; Sulfonamides; ATC:A07EC01 For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.s
Rimexolon C₂₄H₃₄O₃ 370.525 g/mol 49697-38-3 49697-38-3 Lysozyme inhibitor Not Availables
Colestipol C₁₁H₂₈ClN₅O 281.826 g/mol 50925-79-6 50925-79-6 Amidase Operon inhibitor Not Availables
000002-Amino-4-(hydroxymethyl-phosphinyl)butansäure C₅H₁₂N₁O₄P₁ 181.128 g/mol 51276-47-2 51276-47-2 Antithyroid Agents; ATC:H03B For the treatment of hyperthyroidism, goiter, Graves disease and psoriasis.s
Trimetrexat C₁₉H₂₃N₅O₃ 369.418 g/mol 52128-35-5 52128-35-5 Anti-Anxiety Agents; GABA Modulators; Hypnotics and Sedatives; ATC:N05BA04 For treatment of anxiety disorderss
Dipivefrin C₁₉H₂₉NO₅ 351.437 g/mol 52365-63-6 52365-63-6 2,3,4,5-Tetrahydropyridine-2-Carboxylate N- inhibitor Not Availables
Pancrelipase C₅₈₅₀H₈₉₀₂N₁₆₀₆O₁₇₃₉S₄₉ 131125.6 53608-75-6 53608-75-6 Anti-Bacterial Agents; ATC:J01DC11 For the treatment of infections caused by susceptible organisms.s
Dezocin C₁₆H₂₃NO 245.36 g/mol 53648-55-8 53648-55-8 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Nicardipin C₂₆H₂₉N₃O₆ 479.525 g/mol 55985-32-5 55985-32-5 Dietary supplement; Micronutrient; ATC:N02BA03; ATC:N07AX02 For nutritional supplementation, also for treating dietary shortage or imbalances
Valrubicin C₃₄H₃₆F₃NO₁₃ 723.644 g/mol 56124-62-0 56124-62-0 Antinarcotic Agents; Depressants Opioid-induced respiratory depressions
Torsemid C₁₆H₂₀N₄O₃S 348.421 g/mol 56211-40-6 56211-40-6 Bronchodilator Agents; Muscarinic Antagonists; Parasympatholytics; ATC:A03AB15 Used in the treatment of peptic ulcer, gastric hypersäureity, and hypermotility in gastritis and pylorospasm, and in the treatment of hyperhidrosis (excessive perspiration).s
Cefmetazol C₁₅H₁₇N₇O₅S₃ 471.538 g/mol 56796-20-4 56796-20-4 Putative Clc Family, Chlorine Transport Prot inhibitor Not Availables
abequose C₆H₁₂O₄ 148.158 g/mol 56816-60-5 56816-60-5 Lck Tyrosine Kinase inhibitor Not Availables
Clavulanat C₈H₉NO₅ 199.161 g/mol 58001-44-8 58001-44-8 Antiemetics; Antipsychotics Used to prevent and treat nausea and vomiting associated with anesthesia and surgery, administered intramuscularly or intravenously.s
Carboprosttromethamin C₂₁H₃₆O₅ 368.508 g/mol 58551-69-2 58551-69-2 Cytidine Monophosphate Kinase inhibitor Not Availables
Butorphanoltartrat C₂₁H₂₉NO₂ 327.461 g/mol 58786-99-5 58786-99-5 N-Acetyllactosaminide Alpha-1,3-Galactosyltr inhibitor Not Availables
Acyclovir C₈H₁₁N₅O₃ 225.205 g/mol 59277-89-3 59277-89-3 Cholinergic Agonists; Nootropics For use in possible or probable dementia of the Alzheimer type .Used in the treatment of tapeworm infections
Ceforanid C₂₀H₂₁N₇O₆S₂ 519.556 g/mol 60925-61-3 60925-61-3 Trypsinogen inhibitor Not Availables
Rifapentin C₄₇H₆₄N₄O₁₂ 877.031 g/mol 61379-65-5 61379-65-5 Guanylate Kinase inhibitor Not Availables
000004-[[[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinon]] C₁₆H₂₁N₁O₃ 275.347 g/mol 61413-54-5 61413-54-5 Cytosine Deaminase inhibitor Not Availables
Dirithromycin C₄₂H₇₈N₂O₁₄ 835.074 g/mol 62013-04-1 62013-04-1 Antineoplastic Agents For treatment of cutaneous T-cell lymphomas
Progabid C₁₇H₁₆ClFN₂O₂ 334.772 g/mol 62666-20-0 62666-20-0 Antineoplastic Agents; ATC:L01XX03 For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.s
Nilutamid C₁₂H₁₀F₃N₃O₄ 317.221 g/mol 63612-50-0 63612-50-0 Dietary supplement; Micronutrient; ATC:A11HA06; ATC:C10AX07 For nutritional supplementation, also for treating dietary shortage or imbalances
Oxiconazolnitrat C₁₈H₁₃Cl₄N₃O 429.126 g/mol 64211-46-7 64211-46-7 Antituberculosis Agents; ATC:J04AA01 For the treatment of tuberculosiss
Bepridil C₂₄H₃₄N₂O 366.54 g/mol 64706-54-3 64706-54-3 Peroxiredoxin 5 inhibitor; Ras-Related Protein Rab-9A inhibitor Not Availables
Butoconazol C₁₉H₁₇Cl₃N₂S 411.776 g/mol 64872-77-1 64872-77-1 Dihydroorotate Dehydrogenase A inhibitor Not Availables
coenzym f420 C₂₉H₃₅N₅O₁₈P₁ 772.592 g/mol 64885-97-8 64885-97-8 Antineoplastic Agents; Analgesics; ATC:L01DB07 For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosiss
Alclometason C₂₈H₃₇ClO₇ 521.042 g/mol 66734-13-2 66734-13-2 Anti-bacterial Agents; Penicillins; ATC:J01CA12 For the treatment of polymicrobial infections.s
Encainid C₂₂H₂₈N₂O₂ 352.47 g/mol 66778-36-7 66778-36-7 Anti-Ulcer Agents; Histamine H2 Antagonists; ATC:A02BA02; ATC:A02BA07 Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).s
Fenoldopam C₁₆H₁₆ClNO₃ 305.756 g/mol 67227-57-0 67227-57-0 Anti-bacterial Agents; Cephalosporins; ATC:J01DB05 For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogeness
Terconazol C₂₆H₃₁Cl₂N₅O₃ 532.462 g/mol 67915-31-5 67915-31-5 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AB15; ATC:S01BC05 For the short-term (~5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.s
Amlexanox C₁₆H₁₄N₂O₄ 298.293 g/mol 68302-57-8 68302-57-8 Sympatholytics; Antihypertensive Agents; Adrenergic Agents; ATC:C07AB07 For the management of hypertension and prophylaxis treatment of angina pectoris and heart failure.s
Halofantrin C₂₆H₃₀Cl₂F₃NO 500.423 g/mol 69756-53-2 69756-53-2 Anti-Infective Agents, Local; Anti-Infective Agents, Urinary; Antitrichomonal Agents; Monoamine Oxidase Inhibitors; ATC:G01AX06 For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.s
Pefloxacin C₁₇H₂₀FN₃O₃ 333.358 g/mol 70458-92-3 70458-92-3 Analgesics, Non-Narcotic; Cryoprotective Agents; Free Radical Scavengers; Solvents; ATC:G04BX13; ATC:M02AX03 For the symptomatic relief of patients with interstitial cystitis.s
Cefpiramid C₂₅H₂₄N₈O₇S₂ 612.64 g/mol 70797-11-4 70797-11-4 Antihypocalcemic Agents; Antihypoparathyroid Agents; Vitamins (Vitamin D); ATC:A11CC02 Used for the treatment of acute, chronic, and latent forms of postoperative tetany, idiopathic tetany, and hypoparathyroidisms
Dapiprazol C₁₉H₂₇N₅ 325.451 g/mol 72822-12-9 72822-12-9 Cholinesterase Inhibitors; Miotics; Parasympathomimetics For use in the treatment of subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.s
Leuprolid C₅₉H₈₄N₁₆O₁₂ 1209.4 74381-53-6 74381-53-6 Antibiotics; ATC:J04AB01 Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).s
Indecainid C₂₀H₂₄N₂O 308.417 g/mol 74517-78-5 74517-78-5 Antipruritics; Histamine H1 Antagonists; Anxiolytics sedatives and hypnotics; ATC:N05BB01 For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria.s
Interferon Alfa-n1 C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 74899-72-2;9008-11-1 Antioxidants; Anticonvulsants; ATC:N03AX15 For use as adjunctive treatment of partial seizures in adults with epilepsy.s
Divalproex C₁₆H₃₁NaO₄ 310.405 g/mol 76584-70-8 76584-70-8 Antipsychotics; Phenothiazines; ATC:N05AB02 For management of manifestations of psychotic disorders.s
thiorphan C₁₂H₁₅NO₃S 253.318 g/mol 76721-89-6 76721-89-6 Anti-bacterial Agents; Penicillins; ATC:J01CA01; ATC:J01CA02; ATC:J01CA06; ATC:J01CA14; ATC:J01CA15; ATC:S01AA19 For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptocs
Nizatidin C₁₂H₂₁N₅O₂S₂ 331.46 g/mol 76963-41-2 76963-41-2 Cyclodextrin Glycosyltransferase inhibitor Not Availables
(1s,6s,7r,8r,8ar)-1,6,7,8-Tetrahydroxyindolizidin Tetrahydroxyindolizidin C₈H₁₅N₁O₄ 189.211 g/mol 79831-76-8 79831-76-8 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:V06DD Used for nutritional supplementation, also for treating dietary shortage or imbalance.s
Balsalazid C₁₇H₁₅N₃O₆ 357.318 g/mol 80573-04-2 80573-04-2 Anti-Infectives; Enzyme Inhibitors; Quinolones; ATC:J01MA06; ATC:S01AX12 For the treatment of urinary tract infections
NCS-Chromophor C₃₅H₃₃N₁O₁₂ 659.645 g/mol 81604-85-5 81604-85-5 Antidepressants; ATC:N06AG02 For the treatment of depression.s
Anistreplas C₂₅₆₉H₃₉₂₈N₇₄₆O₇₈₁S₄₀ 59042.3 81669-57-0 81669-57-0 Radiation-Sensitizing Agents; Antineoplastic Agents; ATC:L01CA04 For the treatment of non-small-cell lung carcinomas
Treprostinil C₂₃H₃₄O₅ 390.513 g/mol 81846-19-7 81846-19-7 Antihypertensive Agents; Vasodilator Agents; ATC:C02BA01 For the controlled reduction of blood pressure during surgery and in the treatment of hypertensive emergencies.s
Loteprednoletabonat C₂₄H₃₁ClO₇ 466.951 g/mol 82034-46-6 82034-46-6 Dietary supplements; Essential Amino säures; Micronutrients; ATC:V06DD Promotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria.s
000004-hydroxy-3,5-dimethyl-5-(2-methyl-buta-1,3-dienyl)-5h-thiophen-2-on C₁₁H₁₄O₂S₁ 210.290 g/mol 82079-32-1 82079-32-1 Dietary supplement; Essential Amino säure; Micronutrient; ATC:V06DD L-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation.s
Interferon Gamma-1b C₇₆₁H₁₂₀₆N₂₁₄O₂₂₅S₆ 17145.6 82115-62-6;98059-61-1 Antidepressants; Norepinephrine-Reuptake Inhibitors; ATC:N06AA10 For the treatment of depression.s
Tolrestat C₁₆H₁₄N₁O₃F₃S₁ 357.347 g/mol 82964-04-3 82964-04-3 Anti-bacterial Agents; Antituberculosis Agents; ATC:J04AB04 For the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.s
Gadopentetatdimeglumin C₁₄H₂₀N₃O₁₀.₂C₇H₁₇NO₅.Gd 938.2604 g/mol 86050-77-3 86050-77-3 Corticosteroid; Anti Inflammatory; Steroidal; ATC:D07AC18 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.s
Sermorelin C₁₅₄H₂₅₃N₄₅O₄₅S₁ 3487.0 86168-78-7 86168-78-7 Antimalarials; Anti-Infectives; ATC:J01EA01 For the treatment of initial episodes of uncomplicated urinary tract infectionss
Trandolapril C₂₄H₃₄N₂O₅ 430.537 g/mol 87679-37-6 87679-37-6 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:B05XB01; ATC:V06DD Used for nutritional supplementation, also for treating dietary shortage or imbalance.s
Porfimer C₆₈H₇₄N₈O₁₁ 1179.36 g/mol 87806-31-3 87806-31-3 Probable Ammonium Transporter inhibitor Not Availables
Gabaculin C₇H₁₁N₁O₂ 141.169 g/mol 87980-11-8 87980-11-8 Anti-Infective Agents; ATC:J01MA04 For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus, and (3) complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, or Enterobacter cloacae.s
Toremifen C₂₆H₂₈ClNO 405.959 g/mol 89778-26-7 89778-26-7 Anti-Estrogen Agents; Antineoplastic Agents For treatment of prostate cancer, endometriosis, uterine fibroids and premature pubertys
Tiludronat C₇H₉ClO₆P₂S 318.609 g/mol 89987-06-4 89987-06-4 Antidysrhythmic Agents; Sodium channel blockers For the treatment of life-threatening dysrhythmias and sustained ventricular tachycardia.s
Cefdinir C₁₄H₁₃N₅O₅S₂ 395.416 g/mol 91832-40-5 91832-40-5 Antiviral Agents; Immunomodulatory Agents For treatment of venereal or genital warts caused by the Human Papiloma Viruss
Cefprozil C₁₈H₁₉N₃O₅S 389.427 g/mol 92665-29-7 92665-29-7 Hydroxynitrile Lyase inhibitor Not Availables
Glimpirid C₂₄H₃₄N₄O₅S 490.617 g/mol 93479-97-1 93479-97-1 Antineoplastic Agents; Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA02 For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart diseases
Interferon Beta-1b C₉₀₈H₁₄₀₈N₂₄₆O₂₅₃S₆ 20011.0 96778-78-8;145155-23-3 Immunosuppressive Agents; Antivirals; Antiparasitics; Antineoplastic Agents; Anti-inflammatory Agents; Adjuvants; ATC:L04AA13 For the treatment of active rheumatoid arthritis (RA).s
Cisatracuriumbesylat C₆₅H₈₂N₂O₁₈S₂ 1243.48 g/mol 96946-42-8 96946-42-8 Contrast Media; Ultrasound contrast agent Use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.s
Troglitazon C₂₄H₂₇NO₅S 441.541 g/mol 97322-87-7 97322-87-7 Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N02A For the treatment of moderate-to-severe pains
Interferon Alfa-2b C₈₆₀H₁₃₅₃N₂₂₉O₂₅₅S₉ 19269.1 98530-12-2 98530-12-2 Narcotics; Antitussives; Analgesics; Opiate Agonists; ATC:N02AA08; ATC:R05DA04 For treatment and management of pain (Systemic), also used as an Antidiarrheal and as a cough suppressant.s

100000 .. 200000

Pemirolast C₁₀H₈N₆O 228.21 g/mol 100299-08-9 100299-08-9 Antimanic Agents; GABA Agents; Anticonvulsants; ATC:N03AG For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache.s
Butenafin C₂₃H₂₇N 317.467 g/mol 101828-21-1 101828-21-1 Anti-Ulcer Agents; Histamine H2 Antagonists; ATC:A02BA03 For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).s
calyculin A C₅₀H₈₁N₄O₁₅P₁ 1009.181 g/mol 101932-71-2 101932-71-2 Cardiotonic Agents; Bronchodilator Agents; Sympathomimetic; ATC:R03AC For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitiss
huperzin B C₁₆H₂₀N₂O₁ 256.347 g/mol 103548-82-9 103548-82-9 Anticholinergic Agents; Antispasmodics; Antimuscarinics; Antispasmodics; ATC:A03BA For the treatment of functional bowel/irritable bowel syndromes
Moexipril C₂₇H₃₄N₂O₇ 498.568 g/mol 103775-10-6 103775-10-6 Antiparkinson Agents; Antidyskinetics; Antiparkinson Agents; Muscarinic Antagonists; ATC:N04AA04 For the treatment of Parkinson's Disease (especially drug induced)s
Agalsidase Beta C₂₀₂₉H₃₀₈₀N₅₄₄O₅₈₇S₂₇ 45351.6 104138-64-9 104138-64-9 Antiparkinson Agents; Antidyskinetics; ATC:N04AA For treatment and management of Parkinson's disease.s
Nateglinid C₁₉H₂₇NO₃ 317.423 g/mol 105816-04-4 105816-04-4 Beta-Lactamase inhibitor Not Availables
Tenecteplas C₂₅₆₁H₃₉₁₉N₇₄₇O₇₈₁S₄₀ 58951.2 105857-23-6 105857-23-6 Serine/Threonine Protein Phosphatase Pp1-Gam inhibitor Not Availables
Doxacuriumchlorid C₅₆H₇₈Cl₂N₂O₁₆ 1106.13 g/mol 106819-53-8 106819-53-8 Glucose-6-Phosphate 1-Dehydrogenase inhibitor Not Availables
Cevimelin C₁₀H₁₇NOS 489.565 g/mol 107233-08-9 107233-08-9 Anti-bacterial Agents; Tetracyclines; ATC:D06AA03; ATC:G01AA07; ATC:J01AA06; ATC:S01AA04 Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.s
Zafirlukast C₃₁H₃₃N₃O₆S 575.676 g/mol 107753-78-6 107753-78-6 Anti-bacterial Agents; Cephalosporins; ATC:J01DD08 For use in the treatment of the following infections when caused by susceptible strains of the designated microorganisms:s
Ridogrel C₁₈H₁₇F₃N₂O₃ 366.334 g/mol 110140-89-1 110140-89-1 Anti-allergic Agents; Antipruritics; Antihistamines; Histamine H1 Antagonists, Non-Sedating; ATC:R06AX13; ATC:R06AX27 For the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the treatment of chronic idiopathic urticaria in patients 2 years of age or olders
Sparfloxacin C₁₉H₂₂F₂N₄O₃ 392.4 g/mol 110871-86-8 110871-86-8 Exo- inhibitor Not Availables
Gatifloxacin C₁₉H₂₂FN₃O₄ 375.394 g/mol 112811-59-3 112811-59-3 Antipsychotics; Anti-Anxiety Agents; Benzodiazepines; Muscle Relaxants, Central; ATC:M03BB02 Used in the management of anxiety and in the treatment of muscle spasm.s
zd1694 C₂₁H₂₂N₄O₆S₁ 458.488 g/mol 112887-68-0 112887-68-0 Adrenergic Uptake Inhibitors For the treatment of hypertension and as an adjunct in the management of angina pectoris.s
Raltitrexed C₂₁H₂₂N₄O₆S 458.489 g/mol 112887-68-0 112887-68-0 Antihistamines; Ophthalmics; ATC:R06AX24; ATC:S01GX10 For the prevention of itching associated with allergic conjunctivitis.s
Enalkiren C₃₅H₅₆N₆O₆ 656.856 g/mol 113082-98-7 113082-98-7 Antineoplastic Agents; Contrast Media For use as a radio-opaque medium for hysterosalpingography and lymphography, and as an antineoplastic agent when part of the iodine is 131-I.s
Olopatadin C₂₁H₂₃NO₃ 337.412 g/mol 113806-05-6 113806-05-6 Anti-ulcer Agents; ATC:A07EC04 For the treatment of mildly to moderately active ulcerative colitis.s
Dofetilid C₁₉H₂₇N₃O₅S₂ 441.567 g/mol 115256-11-6 115256-11-6 Estrogen-Related Receptor Gamma inhibitor Not Availables
Cefditoren Pivoxil C₂₅H₂₈N₆O₇S₃ 620.724 g/mol 117467-28-4 117467-28-4 Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA03 For the treatment of hypercholesterolemia to reduce the risk of myocardial infarction.s
Tazaroten C₂₁H₂₁NO₂S 351.463 g/mol 118292-40-3 118292-40-3 Antihypertensive Agents; ATC:G04CA01 For the treatment of the signs and symptoms of benign prostatic hyperplasia.s
Interferon Alfacon-1 C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19343 118390-30-0 118390-30-0 Antineoplastic Agents; Antiparkinson Agents; Dopamine Agonists; ATC:G02CB03; ATC:N04BC06 For the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.s
Candoxatril C₂₉H₄₁NO₇ 515.638 g/mol 118785-03-8 118785-03-8 Neocarzinostatin inhibitor Not Availables
Gadoteridol C₁₇H₂₉N₄O₇.Gd 559.1277 g/mol 120066-54-8 120066-54-8 Antiviral Agents; Immunomodulatory Agents For treatment of Chronic granulomatous disease, Osteopetrosiss
Ibutilinfumarat C₂₀H₃₆N₂O₃S 384.578 g/mol 122647-32-9 122647-32-9 Radiation-Sensitizing Agents; Vitamins (Vitamin B Complex); ATC:A11HA04 For the treatment of ariboflavinosis (vitamin B2 deficiency).s
Gadodiamid C₁₆H₂₆N₅O₈.Gd.(H₂O)x Not Available 122795-43-1 122795-43-1 Radiation-Sensitizing Agents; Vitamins (Vitamin B Complex); ATC:A11HA04 For the treatment of ariboflavinosis (vitamin B2 deficiency).s
Clofarabin C₁₀H₁₁ClFN₅O₃ 303.677 g/mol 123318-82-1 123318-82-1 Antiparkinson Agents; Antidyskinetics; Skeletal Muscle Relaxants; ATC:M03BC01; ATC:N04AB02 Indicated for the treatment of Parkinson's disease.s
Cinalukast C₂₃H₂₈N₂O₃S 412.546 g/mol 128312-51-6 128312-51-6 Progesterone Receptor inhibitor Not Availables
Arbutamin C₁₈H₂₃NO₄ 317.38 g/mol 128470-16-6 128470-16-6 Estrogens, Non-Steroidal; ATC:G03CB01; ATC:G03CC02 For use in the treatment of atrophic vaginitis and kraurosis vulvae.s
Ganirelix Not Available 1570.4 g/mol 129311-55-3 129311-55-3 2C-Methyl-D-Erythritol 2,4-Cyclodiphosphate inhibitor; Coenzyme A Biosynthesis Bifunctional Protein inhibitor Not Availables
Verteporfin C₄₁H₄₂N₄O₈ 718.794 g/mol 129497-78-5 129497-78-5 Antipruritics; Phenothiazine Derivatives; ATC:D04AA10; ATC:R06AD02; ATC:R06AD05 Used to prevent and relieve allergic conditions which cause pruritus (itching) and urticaria (some allergic skin reactions).s
Gadoversetamid C₂₀H₃₄N₅O₁₀-₃ 504.512 g/mol 131069-91-5 131069-91-5 Anti-anxiety Agents; Adjuvants, Anesthesia; Benzodiazepines; GABA Modulators; ATC:N05CD07 For the short-term treatment of insomnia (generally 7-10 days).s
Paricalcitol C₂₇H₄₄O₃ 416.636 g/mol 131918-61-1 131918-61-1 Antiprotozoals; Antifungals; ATC:J02AC02 For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.s
Insulin Lyspro recombinant C₂₅₇H₃₈₇N₆₅O₇₆S₆ 5808 133107-64-9 133107-64-9 Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA06 For the treatment of hypertension and chronic heart failure.s
Reteplase C₁₇₃₆H₂₆₇₁N₄₉₉O₅₂₂S₂₂ 39589.6 133652-38-7 133652-38-7 Anti-Infectives; Quinolones; ATC:J01MA02; ATC:S01AX13; ATC:S03AA07 For the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrheas
Lubiproston C₂₀H₃₂F₂O₅ 390.462 g/mol 136790-76-6 136790-76-6 Contrast Agents; ATC:V08CA03 For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues as well as lesions with abnormal vascularity in the head and neck. Also used to facilitate the visualization of lesions with abnormal vascularity in the body (excluding the heart).s
Satumomab Pendetid C₆₂₆₈H₉₇₀₈N₁₆₆₆O₁₉₇₁S₄₈ 141478.9 138955-26-7 138955-26-7 Anti-Allergic Agents; Histamine H1 Antagonists; ATC:S01GX06 For the temporary relief of the signs and symptoms of allergic conjunctivitis.s
Adefovir Dipivoxil C₂₀H₃₂N₅O₈P 501.471 g/mol 142340-99-6 142340-99-6 Vasodilator Agents; Antianginals; Antihypertensive Agents; Calcium Channel Blockers; ATC:C08CA01 For the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.s
Imiglucerase C₂₅₃₂H₃₈₅₄N₆₇₂O₇₁₁S₁₆ 55597.4 143003-46-7 143003-46-7 Quinolinate Phosphoribosyltransferase inhibitor Not Availables
Olmesartan Medoxomil C₂₉H₃₀N₆O₆ 558.585 g/mol 144689-63-4 144689-63-4 Antiprotozoal; Antimalarials; ATC:P01BA03 For the treatment of malaria.s
Capromab Not Available Not Available 145464-28-4 145464-28-4 Anti-Ulcer Agents; Topical For treatment of chronic dermal ulcers and severe skin burnss
Oprelvekin C₈₅₄H₁₄₁₁N₂₅₃O₂₃₅S₂ 19047.2 145941-26-0 145941-26-0 Coagulants; Thrombotic Agents For treatment of hemophilia (Christmas diseae)s
Trovafloxacin C₂₀H₁₅F₃N₄O₃ 416.353 g/mol 147059-72-1 147059-72-1 Diagnostic Agents For detection of residueal or recurrent thyroid cancers
Cilomilast [[cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylic säure]] C₂₀H₂₅N₁O₄ 343.422 g/mol 153259-65-5 153259-65-5 Antineoplastic Agents; Antiviral Agents; Immunomodulatory Agents For the treatment of hairy cell leukemia, malignant melanoma, AIDS-related Kaposi's sarcoma, refractory or recurring external condylomata acuminata in patients 18 years of age or older, laryngeal papillomatosis in children and some types of hepatitiss
Marimastat C₁₅H₂₉N₃O₅ 331.408 g/mol 154039-60-8 154039-60-8 Antineoplastic Agents; ATC:L01XX02 For treatment of acute lympocytic leukemia and non-Hodgkins lymphomas
Travoprost C₂₆H₃₅F₃O₆ 500.548 g/mol 157283-68-6 157283-68-6 Serum substitutes For treatment of severe blood loss, hypervolemia, hypoproteinemias
GALNAC-6S n-acetyl-d-galactosamine 6-sulfat C₈H₁₅N₁O₉S₁ 301.268 g/mol 157296-99-6 157296-99-6 Serum substitutes For treatment of severe blood loss, hypervolemia, hypoproteinemias
Insulin Glargin recombinant C₂₆₇H₄₀₈N₇₂O₇₇S₆ 6063 160337-95-1 160337-95-1 Anti-allergic Agents; Ethylenediamine Derivatives; Histamine H1 Antagonists; ATC:D04AA04; ATC:R06AC04 Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.s
Palifermin C₇₂₁H₁₁₄₂N₂₀₂O₂₀₄S₉ 16192.7 162394-19-6 162394-19-6 Anti-bacterial Agents For the treatment of acute bacterial exacerbations of chronic bronchitiss
Becaplermin C₅₃₂H₈₉₂N₁₆₂O₁₅₃S₉ 12294.4 165101-51-9 165101-51-9 Anti-Infectives, local; ATC:D08AA02 Topical antiseptic used mainly in wound dressings.s
Omapatrilat C₁₉H₂₄N₂O₄S₂ 408.537 g/mol 167305-00-2 167305-00-2 Catabolic Alanine Racemase Dadx inhibitor Not Availables
Ibritumomab C₆₃₈₂H₉₈₃₀N₁₆₇₂O₁₉₇₉S₅₄ 143375.5 174722-31-7 174722-31-7 Immunosuppressive Agents; Hypoglycemic Agents; Antiarrhythmic Agents; Sulfonylureas; ATC:A10BB12 For concomitant use with insulin for the treatment of noninsulin-dependent (Type II) diabetes mellitus; For the treatment ofs
Gemifloxacin C₁₈H₂₀FN₅O₄ 389.381 g/mol 175463-14-6 175463-14-6 Free Radical Scavengers; Antioxidants; Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA04 For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemias
Choriogonadotropin alfa Choriogonadotropin C₁₁₀₅H₁₇₇₀N₃₁₈O₃₃₆S₂₆ 25719.7 177073-44-8 177073-44-8 Anesthetics; Antipruritics; Local Anesthetics; ATC:C05AD03; ATC:D04AB04; ATC:N01BA05; ATC:R02AD01 For general use as a lubricant and topical anesthetic on esophagus, larynx, mouth, nasal cavity, rectum, respiratory tract or trachea, urinary tract, vagina. It is also used to suppress gag reflex.s
Eptifibatid C₃₅H₄₉N₁₁O₉S₂ 831.96 188627-80-7 188627-80-7 Antiviral Agents; Immunomodulatory Agents For treatment of relapsing/remitting multiple sclerosiss
Epothilon D C₂₇H₄₁N₁O₅S₁ 491.685 g/mol 189453-10-9 189453-10-9 Antineoplastic Agents, Hormonal For palliative treatment of advanced breast cancer in postmenopausal women.s
Tositumomab C₆₄₁₆H₉₈₇₄N₁₆₈₈O₁₉₈₇S₄₄ 143859.7 192391-48-3 192391-48-3 Neuromuscular Blocking Agents; ATC:M03AC11 For inpatients and outpatients as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation in the ICU.s
Oseltamivirphosphat C₁₆H₂₈N₂O₄ (free base) 312.405 g/mol (free base) 204255-11-8 204255-11-8 Protein Arginine N-Methyltransferase 1 inhibitor Not Availables
Alefacept C₂₃₀₆H₃₅₉₄N₆₁₀O₆₉₄S₂₆ 51801.1 222535-22-0 222535-22-0 Anti-baldness Agents; Antihyperplasia Agents; Skin and Mucous Membrane Agents (84:92.00); ATC:D11AX10; ATC:G04CB01 For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.s
Micafungin C₅₆H₇₁N₉O₂₃S 1270.28 g/mol 235114-32-6 235114-32-6 Antidepressants; ATC:N06AX18 For the treatment of clinical depression.s
Icodextrin Not Available 13,000-19,000 g/mol 337376-15-5 337376-15-5 Antiprotozoals; Anti-bacterial Agents; ATC:J01AA04 For the treatment of bacterial infection including: Brucellosis; Mycoplasma infection; Trachoma; Chronic bronchitis; Acne vulgaris; Chlamydial infections